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Abstract 
 Medulloblastoma	  cells	  do	  not	  contain	  detectable	  amounts	  of	  the	  bZIP	  protein	  Zhangfei.	  	  However,	  previous	  work	  has	  shown	  that	  expression	  of	  this	  protein	  in	  cells	  of	  the	  ONS-­‐76	  line,	  derived	  from	  a	  human	  medulloblastoma,	  causes	  the	  cells	  to	  stop	  growing	  and	  develop	  processes	  that	  resemble	  neuritis	  (a	  characteristic	  of	  differentiated	  neurons).	  	  Zhangfei-­‐expressing	  cells	  eventually	  die.	  	  My	  objective	  was	  to	  determine	  the	  molecular	  mechanisms	  by	  which	  Zhangfei	  influences	  ONS-­‐76	  cells.	  My	  strategy	  was	  to	  infect	  ONS-­‐76	  cells	  with	  adenovirus	  vectors	  expressing	  either	  Zhangfei	  or	  the	  control	  E.	  coli	  protein	  β-­‐galactosidase	  (LacZ)	  and	  then	  to	  compare	  the	  following	  parameters	  in	  Zhangfei	  and	  LacZ-­‐expressing	  cells:	  a)	  markers	  of	  apoptosis,	  autophagy	  and	  macropinocytosis	  (the	  three	  main	  pathways	  of	  cell	  death);	  b)	  transcripts	  for	  genes	  involved	  in	  neurogenesis	  and	  apoptosis;	  c)	  phosphorylation	  of	  peptide	  targets	  of	  selected	  cellular	  protein	  kinases;	  and	  d)	  active	  transcription	  factors.	  	  Zhangfei-­‐expressing	  cells	  appeared	  to	  succumb	  to	  apoptosis	  as	  determined	  by	  the	  expression	  of	  phosphatidylserine	  on	  the	  cell	  surface	  and	  intensity	  of	  nuclear	  staining	  with	  the	  DNA	  dye	  Hoechst.	  	  Increased	  staining	  for	  autophagic	  vesicles	  and	  upregulated	  expression	  of	  autophagy	  response	  genes	  in	  these	  cells	  indicated	  that	  they	  were	  undergoing	  autophagy,	  possibly	  associated	  with	  apoptosis.	  	  My	  analysis	  of	  steady-­‐state	  transcripts	  for	  genes	  involved	  in	  apoptosis	  and	  neurogenesis	  and	  functional	  protein	  kinases	  in	  Zhangfei-­‐expressing	  cells	  indicated	  that	  the	  mitogen-­‐activated	  protein	  kinase	  (MAPK)	  pathway	  was	  active	  in	  these	  cells.	  	  In	  addition,	  I	  found	  that	  the	  transcription	  factor	  Brn3a	  as	  well	  as	  factors	  implicated	  in	  differentiation	  were	  also	  active.	  	  These	  observations	  led	  me	  to	  hypothesize	  that	  Zhangfei	  enhances	  the	  expression	  of	  Brn3a,	  a	  known	  inducer	  of	  TrkA,	  the	  high-­‐affinity	  receptor	  for	  nerve	  growth	  factor	  (NGF).	  	  TrkA	  then	  binds	  in	  an	  autocrine	  manner	  to	  NGF,	  triggering	  the	  MAPK	  pathway	  and	  leading	  to	  differentiation	  of	  ONS-­‐76	  cells	  into	  neuron	  and	  glia-­‐like	  cells,	  eventually	  bringing	  about	  cell	  death	  by	  apoptosis	  and	  autophagy.	  	  I	  tested	  this	  hypothesis	  by	  showing	  that	  Zhangfei	  could	  enhance	  transcription	  from	  the	  isolated	  Brn3a	  promoter,	  that	  ONS-­‐76	  cells	  produce	  NGF	  as	  detected	  in	  a	  bioassay,	  and	  that	  antibodies	  against	  NGF	  and	  inhibitors	  of	  TrkA	  and	  selected	  components	  of	  the	  MAPK	  pathway	  could	  partially	  restore	  the	  growth	  of	  Zhangfei-­‐expressing	  ONS-­‐76	  cells.	  	  My	  work	  supports	  previous	  work	  highlighting	  the	  importance	  of	  NGF-­‐TrkA	  signaling	  in	  the	  outcome	  of	  medulloblastomas	  and	  shows	  how	  Zhangfei	  is	  able	  to	  trigger	  this	  pathway.	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Chapter 1: Introduction 
 
1.1 Literature Review 
 
 The goal of the following literature review is to provide the reader with 
background information on medulloblastoma brain cancer, death pathways in neuronal 
tumors, neuronal differentiation, and the signaling pathways that mediate these processes.  
I will discuss these topics in the context of my hypothesis, in which I propose that 
transcriptional regulator protein Zhangfei activates what appears to be neuronal 
differentiation and programmed cell death in the medulloblastoma cell line ONS-76.  I 
will begin by providing an introduction to medulloblastoma brain cancer, tropomyosin 
related kinase A (TrkA) signaling in neuronal cells, and Zhangfei.  Following that, I will 
provide information on death signaling in neuronal cells by apoptosis, autophagy, and 
macropinocytosis, along with the signaling pathways that activate and control these 
processes.  It should be noted that apoptosis and autophagy have been described as 
mechanisms of programmed cell death, while macropinocytosis, to date, has not.  I will 
conclude the literature review with my rational, hypothesis, and objectives. 
 
1.1.1  Introduction to Medulloblastomas 
 
Medulloblastomas are invasive, rapidly growing brain cancers that generally arise 
in children.  They comprise about 16% of all infant brain tumors, 40% of all cerebral 
tumors in children under the age of 20, and approximately 2.0% of all adult brain cancers 
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(26).  Medulloblastomas are one of the few brain tumors that are able to spread via 
cerebrospinal fluid leading to metastasis to different locations within the brain and spinal 
cord.  Current treatment for medulloblastomas involves excision of the tumor followed 
by radiation, chemotherapy, or both (reviewed in 26).  While these treatments do improve 
survival, it is often at the cost of severe brain damage and loss of quality of life for long-
term survivors.  Additionally, despite treatment, one third of medulloblastomas remain 
incurable (41). 
 
1.1.2 Development of Medulloblastomas 
 
Some medulloblastomas are thought to arise from granule cell precursors (GCP) 
(12, 64).  In normal development (during late embryogenesis and early childhood), 
GCP’s are induced to divide and then migrate to the cerebral core.  This process is 
mediated by the Sonic Hedgehog (148), and Notch signaling pathways (reviewed in 41).  
As the GCP’s divide and migrate, the effects of the Sonic Hedgehog pathway are 
countered by factors such as fibroblast growth factor and the cells differentiate into 
mature granule cell neurons (37, 148).  GCP’s can also differentiate into astroglial cells 
due to the effects of bone morphogenic protein 2 (BMP2) (100).  Cells of the 
medulloblastoma cell line ONS-76 reflect these bipotent characteristics and display 
properties of both glial and neuronal precursors (103, 135).  This bipotency is 
exemplified by the ability of these cells to express major histocapatibility complex I  
(MHC-I) and MHC-II (a characteristic of glial cells); they also express neurofilament 
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protein and enolase 2, characteristic of neuronal cells.  The ONS-76 cell line was created 
by Tamura et al. using a tumor removed from a two year old female in 1987 (135).   
 
1.1.3 Tropomyosin Related Kinase A (TrkA) 
 
Tropomyosin related kinase A (TrkA) belongs to a family of receptor tyrosine 
kinases that include TrkB and TrkC.  These receptors exist in the plasma membrane of 
cells of neuronal origin and act to regulate neuronal survival, proliferation and plasticity.  
Ligands activating these receptors are: NGF (nerve growth factor), brain derived 
neurotrophic factor (BDNF), and neurotrophins 3 and 4 (NT3, NT4).  Upon binding of 
ligand, these receptors dimerize and activate signaling pathways.  The primary signaling 
pathway activated by TrkA is the MAPK (mitogen activated protein kinase) pathway 
(reviewed by Huang et al., 54).  A detailed diagram of the MAPK signaling pathway 
mediated by TrkA is available in Figure 1.1.  TrkA is also known as the high-affinity 
NGF receptor, and as its name suggests, NGF is its primary ligand.  TrkA is expressed at 
relatively low levels in the ONS-76 medulloblastoma cell line in comparison to mature, 
differentiated neurons (143).  The expression of TrkA in neurons is influenced by 
transcription factor Brn3a in addition to other factors (141).  For the sake of clarity, 
MAPK will be used to refer to the MAPK signaling pathway as a collective, while 
ERK1/2 (members of the pathway, also known as MAPK) will be referred to as ERK. 
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Figure 1.1.  MAPK Signaling.  When inactive in the plasma membrane of cells, TrkA exists 
as a monomer. Upon binding of ligand, nerve growth factor, the receptors dimerize and 
undergo auto-trans-phosphorylation in their kinase domain, followed by phosphorylation at 
the SHC binding domain.  This event triggers the beginning steps of the MAPK kinase 
pathway.  SHC is able to bind the phosphorylated receptor via its PTB phosphoprotein 
binding domain.  Binding of SHC results in it’s phosphorylation.  Adaptor protein Grb2 binds 
phosphorylated SHC via its SH2 phosphoprotein-binding domain.  Grb2 may bypass this step 
completely and bind the phosphorylated receptor.  Grb2 is constitutively bound to another 
protein, SOS, via two SH3 protein-binding domains.  SOS is a guanine nucleotide exchange 
factor, and acts as an activator for the next protein in the MAPK pathway, Ras.  Ras is a 
monomeric G-protein with a prenylated C-terminus for association with the plasma 
membrane.  Upon interaction with activated SOS, Ras releases its bounds GDP and 
exchanges it for a GTP.  Activated Ras recruits, binds, and activates Raf by causing a 
dephosphorylation event.  Inactive Raf is phosphorylated at regulatory sites and exists in the 
cytosol bound to the regulatory protein 14-3-3.  Dephosphorylation of Raf results in loss of 
14-3-3, then phosphorylation of Raf by other kinases including PKC (protein kinase C) and c-
Src.  Activated Raf is then able to phosphorylate MEK, which in turn phosphorylates ERK 
(also known as MAPK).  MEK is a dual specificity kinase, meaning that it is capable of 
phosphorylating both tyrosine and threonine residues (which it does to ERK).  
Phosphorylated ERK dimerizes and is imported into the nucleus, where it is able to 
phosphorylate nuclear transcriptional elements and transcription factors (including: Elk-1, 
Egr-1, c-Myc, as well as c-Fos and c-Jun, or known together as AP-1) leading to their 
activation.  Reviewed by Lodish et al. (75).  
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1.1.4 TrkA-Mediated Transcription 
 
Trophic responses to TrkA signaling are mediated through the MAPK signaling 
cascade (62).  The primary transcription factor targets of MAPK signaling include: c-Fos 
(FBJ murine osteosarcoma viral oncogene homolog), c-Jun (Jun proto-oncogene), Egr-1  
(early growth response 1), Elk-1 (ETS oncogene family member 1), c-Myc 
(myelocytomatosis viral oncogene homolog), and AP-1.  Transcription factor AP-1 refers 
to heterodimeric and homodimeric complexes between c-Jun, c-Fos, ATF (activating 
transcription factors), and JDP (Jun dimerization partners) families of transcription 
factors that bind to the AP-1 recognition site in DNA (127).  AP-1 family members have 
been shown to both promote differentiation/survival as well as apoptosis in a very cell-
specific and signal specific manner (4).  AP-1 activation has been shown to play a role in 
neuronal differentiation of mouse bone marrow stromal cells (154).  This differentiation 
is also ERK dependent.  Feng et al. also found that AP-1 activity was required for 
neuronal differentiation (36).  Egr-1 activity is upregulated in the developing brain (83), 
but has also been identified as a candidate to induce apoptosis in conjunction with c-Myc 
(8).  It is clear that the transcription factors targeted by TrkA signaling play a complex 
and highly regulated role in cellular survival and death. 
 
1.1.5 TrkA Retrograde Signaling 
 
After prolonged activation of TrkA, the receptor is endocytosed.  It continues to 
signal under what is called the “retrograde” pathway until the time when it fuses with a 
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degradative vesicle or is recycled (109).  Retrograde TrkA signaling still requires MAPK 
pathway members to mediate its function.  One notable MAPK family member shown to 
mediate retrograde signaling is ERK5.  ERK5 has been shown to be active during 
retrograde signaling and phosphorylate target transcription factors including CREB and 
Mef2 (114, 147).  A diagram of retrograde signaling can be viewed in Figure 1.2. 
 
1.1.6 TrkA in Neuronal Survival, Differentiation and Death 
 
TrkA has been studied for its role in cellular differentiation and promoting 
cellular survival.  Neuronal differentiation involves exit from cell cycle and the growth of 
cellular projections known as neurites.  Neurofilament helps to maintain the shape and 
rigidity of these neurites (57).  Kimmelman et al. found that ectopic expression of RAS 
(Ras protein-specific guanine nucleotide-releasing factor 1; a member of the MAPK 
signaling pathway) in PC12 cells (pheochromocytoma of the rat adrenal medulla) was 
sufficient to induce differentiation (65).  Differentiation was dependent on MAPK 
signaling activation and was detected by neurofilament production, growth-associated 
protein 43 (GAP-43) production, and neurite growth.  Dimitropoulou et al. have shown 
the importance of MEK and ERK activation in the development of chick retinal neurons 
(30).  MEK (mitogen-activated protein kinase kinase 1) and ERK (mitogen-activated 
protein kinase 1) are key members of the MAPK signaling pathway.  To further 
complicate the role of TrkA signaling, these observations are often tissue specific.  
While TrkA signaling is involved in neuronal differentiation and survival, it can 
also mediate the death of neuronal cells (49, 87, 95, 104).  TrkA expression is increased  
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Figure 1.2.  TrkA Retrograde Signaling.  With prolonged stimulation, the 
TrkA receptor is endocytosed where it continues to signal, through ERK5.  Transcription 
factors targeted by retrograde signaling include CREB and Mef2.  Refer to text for further 
detail. 
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in segments of the cerebellum during differentiation, and correlates with a increased 
apoptotis (99).  Expression of TrkA also correlates with lower grade neuroblastoma 
tumors (13, 96) and NGF treatment of medulloblastoma cells expressing TrkA induces 
the death of these cells (95).  TrkA may also direct apoptosis in neuronal cells by induced 
cleavage of the p75 neurotrophin receptor (87).  This cleavage results in the activation of 
the caspase cascade bringing about cell death by apoptosis (139).  Cerebral cavernous 
mal-formation-2 (CCM2) has also been shown to mediate TrkA-induced apoptosis in 
medulloblastoma cells by directly binding to juxtamembrane region of this NGF receptor 
and linking its signaling to cell death pathways (49). 
 
1.1.7 Zhangfei (CREBZF) 
 
Ectopic expression of the protein Zhangfei (CREBZF) in ONS-76 
medulloblastoma cells results in the transcript levels of TrkA increasing by more than ten 
fold, along with cessation of growth followed by what appears to be cellular 
differentiation and cell death (143).  Zhangfei is expressed in mature neurons, but cannot 
be detected in neuronal tumors, including the cell line ONS-76 (1).   
Zhangfei was originally identified as a partner for Host Cellular Factor, a co-
activator of the herpes simplex virus (HSV) transactivator VP16 (77).  It is a potent 
inhibitor of VP16 and HSV replication (1).  Zhangfei is a basic leucine zipper (bZIP), 
meaning it has a basic domain, which in other bZIP proteins binds to elements in the 
promoters of responsive genes.  bZIP proteins also have a leucine zipper domain used to 
interact with other bZIP proteins.  The basic domain of Zhangfei lacks an asparagine 
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residue shown to be critical for promoter recognition in other bZIP proteins and, perhaps, 
as a consequence of this, Zhangfei does not bind known bZIP response elements (52, 77, 
91).  The inability of Zhangfei to bind known bZIP response elements as a homodimer is 
conserved in homologs of other vertebrates, including the Japanese puffer fish (22).  
While Zhangfei does not appear to activate transcription on its own, it may do so in 
association with other bZIP proteins.  bZIP proteins form homodimeric and heterodimeric 
complexes (52, 77).  Zhangfei is no different, although its homodimer has been described 
as relatively unstable, and unable to bind DNA, leading to the hypothesis that Zhangfei 
must form heterodimers in order to act as a transcriptional regulator (52, 77).  One such 
Zhangfei binding partner is ATF4 (activating transcription factor 4, or CREB2).  
Zhangfei was shown to enhance binding of ATF4 to the CRE (cyclic-AMP response 
element) and increase its transcriptional activation in response to MEK1 (mitogen-
activated protein kinase 1) signaling.  Interestingly, MEK1 is a member of the MAPK 
signaling pathway, the primary signaling pathway of TrkA.   
As mentioned previously, Zhangfei has been shown to upregulate the expression 
of TrkA in ONS-76 cells and induce their death (143).  Many studies also link the 
expression of TrkA to cell death (see section 1.1.6).  The following sections explore 
cellular death pathways and the molecular mechanisms by which they are regulated. 
 
1.1.8 Death Pathways 
 
An important characteristic of cancer cells is their uncontrolled division coupled 
with a resistance to cell death.  Thus, when studying medulloblastoma tumor cells it 
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becomes important to understand the mechanisms of induced cell death, cessation of 
division, and differentiation.  Three methods of programmed cell death appear in the 
literature: apoptosis, macropinocytosis, and autophagy (48, 72, 118). 
 
1.1.9 Apoptosis 
 
Apoptosis is a complex series of biochemical and morphological events that lead 
to cell death.  The term apoptosis was first used by Kerr et al. in 1972, in which he 
described a distinct “mechanism of controlled cell deletion, which appears to play a 
complementary but opposite role to mitosis” (63).  Work by Horvitz et al. in 1999 on the 
developing nematode Caenorhabditis elegans led to much of our current understanding 
on the role of apoptosis in developing organisms, the molecular and genetic means of 
apoptosis, and the evolutionary conservation of these pathways (53).  Apoptosis is so 
well conserved in fact, there has been considerable documentation of this process 
occurring in plants (129, 144, 145).  Apoptosis is also known to dominate the process of 
tadpole tail regression during Xenopus metamorphosis (121), shaping the middle ear (35, 
115, 150), and in creating the spaces between our fingers and toes (156). 
Apoptosis occurs as a natural and essential part of everyday physiology.  It is 
required for the maintenance of cellular homeostasis, the development and preservation 
of the immune system, as a defense mechanism against infection and toxins, and in 
eliminating cells damaged following irradiation or chemical exposure.  It has been 
estimated that a human adult loses 10 billion cells per day to apoptosis to allow for tissue 
homeostasis alone (113).  Apoptosis is critical for the removal of autoreactive immune 
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cells, and furthermore, it is the mechanism by which natural killer and cytotoxic T-cells 
protect our bodies against infection, reviewed in (34).  Irreversible damage to DNA by 
either irradiation or noxious chemicals may trigger apoptosis (98).  This response is 
essential to prevent mutation, cancer, and to mediate effective cleanup of damaged cells 
(67, 76, 116). 
 
1.1.10 Apoptosis and Cancer 
 
The process of apoptosis becomes especially significant when studying cancer.  
Apoptosis, being a genetically coded process, may be affected by mutation.  Mutations in 
apoptotic machinery or regulatory proteins may cause or contribute to disease, such as 
tumorigenesis (76, 136).  A key characteristic of metastasis is the ability of a cancerous 
cell to survive in the absence of contact with other cells following its break from its tissue 
of origin, and invasion into other tissues.  The work by Frisch et al. shows that disruption 
of epithelial cell-cell or cell-matrix interactions can lead to apoptosis (38).  The process 
of apoptosis occurring following loss of contact to a substratum is termed “anoikis”.  
Aside from naturally induced apoptosis in cancerous cells, the majority of anti-cancer 
agents used today, such as chemotherapeutic agents and radiation, work by inducing 
apoptosis (119). 
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1.1.11 The Morphology of Apoptosis 
 
Apoptosis is characterized by a set of morphological changes.  Early changes 
when a cell first begins to undergo apoptosis include cell shrinkage and pyknosis 
(chromatin condensation) (63).  This process is followed by budding of the plasma 
membrane, karyorrhexis (fragmentation of the nucleus), exposure of phosphatidylserine 
to the outer leaflet of the plasma membrane, degradation of chromosomal DNA, and 
cytoskeletal reorganization (46, 123).  An important feature of apoptosis is that the 
plasma membrane maintains its integrity throughout this process, as to not leak any 
cellular contents or produce an inflammatory response.  Phosphatidylserine along with 
other “eat me” signals facilitate engulfment of the apoptotic bodies (55).   
Apoptosis is distinguishable from oncosis, cell death brought about in an 
unprogrammed manner.  Oncosis, often misused as the term necrosis, and in contrast to 
apoptosis, is an energy independent process that usually affects a large number/area of 
cells at any one given time.  Oncosis is usually due to direct disruption of the cell 
membrane or interruption of cellular nutrient supplies (82, 157).  Other features of 
oncotic cell death include: cell swelling, loss of plasma membrane integrity, an 
inflammatory response, and swollen or ruptured mitochondria, reviewed in (32). 
 
1.1.12 The Three Arms of Apoptosis 
 
The molecular pathways involved in apoptosis are highly regulated and complex.  
There are three pathways known to be involved in apoptotic signaling: extrinsic, intrinsic, 
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and the perforin/granzyme pathway.  All three pathways converge at a single point, 
caspase 3 activation.  Caspase 3 activation is the first step in the execution stage of 
apoptosis.  Figure 1.3 outlines these three death pathways. 
 
1.1.13 Extrinsic Pathway 
 
Activation of extrinsic apoptotic signaling involves interaction between death 
receptors and their cognate ligand.  Death receptors belong to the tumor necrosis family 
of receptors.  Examples of such receptor-ligand death receptors include: TNFα/TNFR1 
(tumor necrosis factor alpha/tumor necrosis factor receptor 1), FASL/FASR (tumor 
necrosis factor superfamily member 6 and receptor), and APO3/DR3 (apoptosis inducing 
receptor 3/death receptor 3) (5, 125).  Receptor signaling subsequently leads to DISC 
(death-inducing signaling complex) formation.  DISC refers to an adaptor protein- 
initiator caspase complex that is involved in the activation of caspase 8, which in turn, 
activates caspase 3 (108).  Caspase 3 activation is critical is the execution stage of 
apoptosis, bringing about the phenotypic characteristics of apoptosis described above 
(110).  Caspases exist as inactive proenzymes (procaspases) within the cell.  Activation of 
a caspase often allows for the activation of the following caspase in the sequence by 
proteolytic cleavage (50).  This sequence of caspase activation is referred to as a cascade, 
hence the term “caspase cascade”.  Although caspase 3 appears to be the convergence 
point of all three apoptotic pathways, caspase 3 independent apoptosis has been 
documented.  Didenko et al. found that apoptosis in rat brain ischemia cases did not rely 
on caspase 3 upregulation or activity (29).  Brown et al. report that the cell line WEHI- 
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Figure 1.3.  The Three Arms of Apoptosis Induction.  Apoptosis may be achieved 
utilizing the extrinsic, intrinsic, or perforin/granzyme pathways.  All three pathways 
converge at caspase 3 activation, often the first step in the execution pathway leading to 
cell death (figure adapted from Elmore et al., 32). 
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231 undergoes caspase 3 independent apoptosis upon the addition of transforming growth 
factor beta (TGFβ) (14).  Tumor necrosis factor alpha (TNFα) has also been reported to 
induce caspase 3 independent cell death in neuroblastoma cells (3). 
 
1.1.14 Intrinsic Pathway 
 
Activation of the intrinsic pathway of apoptosis may be brought about by 
numerous stimuli that signal a mitochondrial response.  Such factors include: loss of 
growth factor stimulation, hypoxia, toxins, radiation, free radicals, and infection by a 
pathogen (reviewed in 32).  Sufficient stimulation by any, or all, of these factors results in 
a loss of mitochondrial membrane potential and the leakage of pro-death substrates into 
the cell, such as Smac/DIABLO and cytochrome C (122).  Smac/DIABLO works to 
promote apoptosis by inhibiting IAP’s (inhibitors of apoptosis).  Cytochrome C forms a 
complex with Apaf-1 (apoptotic peptidase activating factor 1) and procaspase 9 to form 
the “apoptosome.”  This results in the activation of procaspase 9.  The apoptosome is then 
able to activate caspase 3 and initiate the process of apoptosis (20).   
 
 
1.1.15 Perforin/Granzyme Pathway 
 
The perforin/granzyme pathway of apoptosis is used by cytotoxic T-cells and 
natural killer T-cells to kill detectable tumor cells, or cells infected by pathogens.  This 
mechanism involves the insertion of pore-forming molecules (perforin) into the target 
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cells plasma membrane.  Following this, granules are released that travel through these 
pores into the target cell.  One of these granules, granzyme B, is able to activate caspase 
10, which in turn, activates caspase 3 to bring about death signaling.  It should be noted 
that cytotoxic T-cells and natural killer cells also utilize the extrinsic apoptosis pathway 
by FASL/FASR signaling (15).  The perforin/granzyme pathway is reviewed by Trapani 
et al. (137).   
 
1.1.16 p53 and Apoptosis 
 
 Tumor protein 53 (p53) is one of the most highly recognized and studied tumor 
suppressor genes.  TrkA has been shown to induce the expression of p53 in 
neuroblastoma cells, resulting in apoptosis (69).  Work on NGF-mediated differentiation 
of PC12 cells has indicated a possible role for p53 in regulating TrkA levels (158).  It was 
also found that phosphorylation of p53 on serine residues 6 and 9 may be required for 
proper p53-induced cessation of cellular division, and that phosphorylation of these 
residues was MAPK signaling dependent (25).  Active and stable p53 is able to act as a 
transcription factor that has roles in regulating cell cycle, apoptosis, and differentiation 
(39).  Although p53 appears to be the most commonly mutated gene in human cancers, 
medulloblastomas rarely contain mutated p53 sequences (18).  Castellino et al. suggests 
that overexpression of WIP1 (an antagonist to p53-mediated apoptosis) may play a role in 
the tumorgenicity of medulloblastomas (18).  
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1.1.17 Introduction to Autophagy 
 
Autophagy is the process by which a cell uses degradative lysosomes to degrade 
or recycle organelles and proteins.  This process occurs naturally and regularly and is 
characterized by the formation of double membrane vesicles that enclose cellular 
constituents and fuse with lysosomes (68).  Autophagy was first characterized as a 
response to cellular starvation. With further insight, it also appears to have a role in 
neurological disorders, cancer, organelle clearance and programmed cell death, notably in 
neurons (68, 84).  The process of autophagy may be broken down into several sequential 
steps: induction, sequestration, degradation, and recycling of degraded constituents. 
 
1.1.18 Autophagy as a Mechanism of Programmed Cell Death 
 
Once thought to be only a pathway promoting cellular survival in times of 
nutrient starvation and in the recycling of dated cellular machinery, there is mounting 
evidence for autophagy as a mechanism of programmed cell death.  In 1990 Clarke et al. 
devised a method of classification for programmed cell death, defining apoptosis as type 
1 cell death, and autophagy as type 2 cell death based on the previous work of Scheichel 
et al. in 1973 (21, 126).  Hansen et al. have discovered a novel pathway in which nerve 
growth factor stimulation of TrkA-transfected glioblastoma cells results in cell death by 
overactivation of autophagy (48).  Confirmation of autophagy was performed by staining 
of acidic vacuoles with acridine orange, LC3-II production, and electron microscope 
photographs of cells containing many, large autophagic vacuoles.  Bergmann et al. found 
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that autophagy was involved in Drosophila melanogaster development in a programmed 
manner (7).  Xue et al. offer more support to the existence of autophagy as a death 
mechanism by showing that HELA, CHO, and cervical neurons treated with a death-
inducing factor and an inhibitor of apoptosis are committed to cell death by autophagy 
(153).  In contrast to cell death by apoptosis, autophagic cell death presents with only 
partial chromatin condensation, no DNA laddering, and nuclear fragmentation only at late 
stages.  Plasma membrane budding may occur in both cases (reviewed in 44). 
 
1.1.19 Autophagy and Cancer 
 
The literature seems to be split on the role of autophagy in tumor biology.  Some 
authors provide opinions suggesting that autophagy promotes tumor survival, while 
others suggest the opposite.  Boya et al. and Lum et al. performed experiments limiting 
nutrients to tumor cells thereby increasing the rate of autophagy, and prolonging cellular 
survival (10, 79).  In the hypoxic, nutrient-deprived environment of a tumor, this logic 
dictates that autophagy may provide a pro-tumor survival mechanism.  In contrast to this 
idea, Beclin 1, an autophagy response gene, has been shown to act as a tumor suppressor 
gene in mice (111, 155).  Also, the very idea that autophagy has been proposed as 
programmed cell death type 2, seems to contradict the idea that it would promote the 
survival of tumor cells.  What is clear is that much more research into the role of 
autophagy in cancer is required.   
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1.1.20 Induction of Autophagy 
 
Like apoptosis, the process of autophagy appears to be highly conserved, with 
detection in plants and yeast as well as animals (93, 134).  Autophagy is generally 
upregulated in times of nutrient starvation.  It has been suggested that autophagy is 
regulated, at least in part by the endocrine system, notably by insulin and glucagon in-
vivo (92, 94).  In-vitro studies utilize serum and/or amino acid starvation to activate 
autophagy.  Much of hormone/growth factor/nutrient availability is thought to feed into 
mTOR (mammalian target of rapamycin) signaling (42, 45).  TOR is thought to be a key 
regulator of autophagic induction, although how TOR actually detects these levels 
remains controversial (reviewed by Jung et al., 58). 
  
1.1.21 Autophagosome Formation and Sequestration 
 
The process of autophagy begins with a phagophore (isolation membrane) 
surrounding the organelle or protein complex to be degraded.  After total sequestration 
has occurred, the resulting structure is known as an autophagosome.  Preliminary work 
and discovery of autophagic response genes was performed in yeast.  31 autophagy 
related (Atg) genes have been discovered to date, and are reviewed in detail (66, 131).  
Hallmarks of the autophagic process include cleavage of LC3 I (microtubule-associated 
protein 1 light chain 3 - 1) to LC3 II (microtubule-associated protein 1 light chain 2 - 2) 
for incorporation into the autophagic membrane, and upregulation of Beclin 1 (17, 60).  
The process of autophagy is outlined in Figure 1.4, in terms of autophagy response genes. 
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Figure 1.4.  A Brief Overview of Autophagy.   The above figure outlines the 
process of autophagy in terms of autophagy response genes.  Beclin 1 is the mammalian 
homolog of ATG6, and LC3 is the mammalian homolog of ATG8.  Refer to sections 
1.1.20 - 1.1.22 for further detail. 
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1.1.22 The Autophagosome and the Autophagolysosome 
 
After completion of the autophagosome, the compartment will fuse with 
lysosomes (or vacuoles in the case of plants and yeast).  The contents of the 
autophagosome are degraded, along with the inner membrane of this double membrane 
structure and the structure is now referred to as a mature autophagolysosome (92).  
Larger molecules are broken down into their constituents to be recycled by the cell.  
 
1.1.23 MAPK and JNK Signaling in Autophagy 
 
MAPK signaling has been shown to inhibit the process of autophagy (24).  In fact, 
MAPK signaling has been shown to activate mTOR, resulting in the inhibition of the 
autophagic induction process.  Conversely, inhibition of mTOR has been shown to 
upregulate MAPK signaling (2).  Wang et al. have shown that both depletion of ERK or 
inhibition of MEK leads to the inhibition of autophagy, suggesting a necessary role for 
MAPK signaling in inducing autophagy (146).  These results may reinforce the 
importance of tissue specificity in cell signaling, a negative feedback loop, or perhaps a 
need for further exploration on the role of MAPK signaling in the induction of 
autophagy. 
 In contrast to the “grey area” of MAPK signaling in autophagy, the literature 
appears to be quite clear on the role of JNK signaling in autophagy.  Zhang et al. found 
that Fas (tumor necrosis factor receptor superfamily member 6)-mediated autophagy is 
dependent on JNK signaling and that autophagy is inhibited with the use of a JNK 
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inhibitor (SP600125) (159).  JNK was also found to be essential for the maintenance and 
survival of neurons by regulating FoxO (forkhead box 01)-dependent autophagy (152).  
Aside from its role in autophagy, JNK is also known to play a major role in the regulation 
of apoptosis, reviewed by Kanda et al. (61). 
 
1.1.24 Introduction to Macropinocytosis 
 
Macropinocytosis is a form of cellular endocytosis in which the cell takes up bulk 
amounts of extracellular fluids and dissolved solutes.  Macropinocytosis has been the 
target of study for dendritic cell class II MHC restricted antigen uptake, apoptotic body 
uptake, as an entry mechanism for some viruses, and as a mechanism of cell death (33, 
51, 89, 133).  Macropinosomes differ from autophagosomes due to the fact that they are 
single membrane, rather than double membrane structures.  The characteristics of 
apoptosis, autophagy and macropinocytosis are compared and contrasted in Table 1.5. 
 
1.1.25 Mechanism of Macropinocytosis 
 
The intake machinery required for macropinocytosis is described as a singular 
cellular lamellipodium that facilitates ruffling or folding of the plasma membrane (33, 
133).  These ruffles contain “cup shaped invaginations” (132).  The fold seals in on itself, 
forming a vacuole known as a macropinosome.  Macropinocytosis is easily 
distinguishable from micropinocytosis, which utilizes clatherin-coated, and small 
uncoated vesicles to take in relatively small amounts of substrate, usually in a selective  
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Table 1.5. A Comparison Between Apoptosis, Autophagy, and Macropinocytosis. 
Process Apoptosis Autophagy Macropinocytosis Oncosis 
Cell Shrinkage (63) x    
Pyknosis (63, 82) x   x 
Plasma Membrane Blebbing (32) x    
Karyorrhexis (32, 82) x   x 
Cell Swelling (82)    x 
Karyolysis (82)    x 
Distension of Endoplasmic Reticulum (82)    x 
ATP and Caspase Depletion (157) x   x 
Cytoplasmic Vacuole Formation (140, 157)    x 
Swollen or Condensed Mitochondria (140, 157)    x 
Plasma Membrane Loss of Integrity (140, 157)    x 
Caspase Cascade Activation (23, 86, 102) x x x  
DNA Fragmentation (9,102, 140) x  x  
Phosphatidylserine Exposed to Plasma 
Membrane Outer Leaflet (11) 
x    
Cytochrome C, Smac/DIABLO Release from 
Mitochondria (122) 
x    
Beclin 1 (ATG6) Upregulation (72)  x   
ATG5, ATG9 Upregulation (72)  x   
LC3 Cleavage/Acidic LC3-II Positive Double 
Membrane Vacuole Accumulation (72, 102) 
 x   
Incorporation of Organelles in Vacuoles (86)  x   
Single Membrane Vacuole Accumulation (102)   x  
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manner.  Macropinocytosis on the other hand, takes in large amounts of extracellular 
fluid and solute macromolecules in a more or less unselective manner (133). 
 
1.1.26 Macropinocytosis as a Death Pathway 
 
Recently, macropinocytosis has been proposed as a possible mechanism of cell 
death.  Li et al. have reported that NGF stimulation of DAOY strain medulloblastoma 
cells transfected to express TrkA results in cell death by hyperstimulation of 
macropinocytosis (72).  Confirmation of macropinocytosis involved uptake of 
monodansyl cadaverin (MDC) into single membrane vacuoles, LC3-II production, and 
cell death independent of key members in autophagy and apoptosis pathways. 
 
1.2 Rational, Hypothesis and Objectives 
 
Previous results show that expression of Zhangfei in ONS-76 cells results in the 
growth of neurite-like projections followed by cell death (143).  Zhangfei has also been 
shown to increase the expression of TrkA (143).  The TrkA pathway has been shown to 
lead to neuronal cell death as well as differentiation (48, 72, 95, 104, 118).  My 
hypothesis was that Zhangfei upregulates the expression of the high-affinity nerve growth 
factor, TrkA, resulting in the activation of signaling pathways that bring about possible 
differentiation followed by cell death. 
My objective was to determine the molecular pathway(s) by which Zhangfei 
induces differentiation and/or cell death in ONS-76 medulloblastoma cells, and to 
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determine the type of cell death being activated.  A photographic timeline of ONS-76 
cells expressing Zhangfei or control protein, β-galactosidase, was performed to visibly 
show the phenotype of Zhangfei-expressing cells.  A WST-1 proliferation and viability 
assay was used assess the viability of cells expressing Zhangfei.  By using a combination 
of quantitative real-time polymerase chain reaction (qRT-PCR) arrays for detecting up-
regulated gene transcripts, kinome arrays for identifying active protein kinases, and  
transcription factor analysis, potential pathways activated in Zhangfei-expressing ONS-
76 cells were identified.  Chemical inhibitors of kinases were used to elucidate and 
confirm the suspected signaling pathways.  Next, a combination of fluorescent 
microscopy and flow cytometry guided the analysis of cellular death pathways, apoptosis, 
autophagy, and macropinocytosis.  
The results suggest that Zhangfei acts by increasing the expression of Brn3a, a 
known regulator of TrkA transcription.  TrkA activation by autocrine nerve growth factor 
stimulation could bring about downstream signaling that ultimately leads to cellular 
differentiation and death.  
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Chapter 2: Materials and Methods 
 
2.1 Cell Culture 
The human medulloblastoma cell line ONS-76, (135), was obtained from Michael 
Taylor (University of Toronto, Canada).  These cells were growth in Dulbecco’s 
Modified Eagle Medium (D-MEM, Invitrogen, Carlsbad, CA, USA) high glucose with 
10% fetal bovine serum (FBS, Invitrogen) and 1% penicillin–streptomycin (Invitrogen).  
This combination will be referred to as “complete media.”  Cells were cultured in a CO2 
incubator set at 37oC and 5% CO2 in 75cm2 Falcon culture flasks or 6-well plates (BD 
Falcon, Mississauga, ON, Canada).  The cell cultures were diluted 1/5 every three days.  
ONS-76 is an adherent cell line, as such, 0.05% Trypsin-EDTA (Invitrogen) was used to 
remove cells from the culture flasks and wells (3ml per culture flask, 250 µl per well in a 
6-well plate).  
D17 cells, obtained from American Type Culture Collection (ATCC), were grown 
in Alpha medium (Invitrogen) containing 10% FBS. 
PC12 cells (provided by D. D. Mousseau, University of Saskatchewan) were 
grown in RPMI 1640 supplemented with 10% heat-treated horse serum, 5% fetal bovine 
serum, and 1% penicillin–streptomycin.  Cells were grown on plates coated with collagen 
as follows: six-well plates were incubated at room temperature for 1 h with 2 ml of a 0.02 
N acetic acid solution containing 50 µg/ml rat tail collagen (VWR). Plates were then 
rinsed with sterile PBS and used immediately.  All components ordered from Invitrogen 
unless otherwise stated. 
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2.2 Adenovirus Vectors Expressing Zhangfei and β-galactosidase (LacZ) 
 
These adenovirus vectors were constructed, grown, and purified using the Adeno-
X Expression System (Clontech, Mountain View, California, USA).  They were created 
previously in our laboratory (following the protocol outlined in 91).  ONS-76 cells were 
infected with Adeno-Zhangfei (expressing human Zhangfei), Adeno-LacZ (expressing E. 
coli β-galactosidase) or mock-infected.  Infection occurred by replacing the complete 
Dulbecco media from cells plated 24 hours previously, with 250 µl of OptiMEM 
(Invitrogen) diluted virus at a multiplicity of infection (MOI) of 100 plaque forming units 
(pfu) per cell.  Cells were incubated at 37oC in the CO2 incubator for one hour, with 
rocking every 15 minutes.  After the hour, 2 ml of complete Dulbecco’s media was 
added. 
  
2.3 WST-1 Cell Proliferation and Viability Assay 
 
ONS-76 cells were plated in 96-well flat bottom Falcon plates at a concentration 
of 1x105 cells per ml (100 µl per well) for a total of 1x104 cells per well.  Four hours later 
the media was removed, cells were rinsed with 100 µl of phosphate buffered saline (PBS) 
and then infected with either Adeno-Zhangfei or Adeno-LacZ (25 µl per well, MOI of 
100 pfu/ml).  After infection, 175 µl of fresh complete media was added to the wells.  
This media contained chemical inhibitors, if required (see Table 2.1 for concentrations).  
Plates were returned to the CO2 incubator for 48 hours.  48 hours post-infection (hpi), 20  
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Table 2.1. Chemical Inhibitors, Concentrations and Scientific Names. 
 
 
 
 
 
µl per well of WST-1 reagent (Clontech) was added.  Cells were returned to the incubator 
for 1 hour before absorbance was measured at 450 nm (reference wavelength 650 nm) on 
a Molecular Devices, Vmax microplate reader.  This colorimetric assay is based on the 
cleavage of the WST-1 reagent to a dye (detectable at 450 nm).  Cleavage is 
accomplished by the mitochondrial enzyme succinate-tetrazolium reductase in 
metabolically active cells.  The absorbance measured is directly related to the number of 
viable cells.  All cell treatments were plated in triplicate.  All chemical inhibitors were 
purchased from EMD Biosciences, VWR distributor, Mississauga, Ontario, Canada).  
Inhibitor Concentration Used 
JNK inhibitor SP600125 25 µM 
p53 inhibitor (Pifithrin α) 25 µM 
MEK inhibitor PD98059 50 µM 
CK1 inhibitor D4776 40 µM 
TrkA inhibitor 25 µM 
ERK activation inhibitor II 25 µM 
Apoptosis inhibitor M50054 420 µM 
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Rabbit anti-TrkA (Biovision, Mountain View, CA, USA) was used at a concentration of 
1:500.  Goat anti-NGF (nerve growth factor) and NGF were purchased from Cedarlane 
(Burlington, Ontario, Canada).  Anti-NGF was used at a dilution of 1:100.  This dilution 
was optimized to neutralize the effects of NGF at a concentration of 50 ng/ml.  
 
2.4 mRNA Purification and cDNA Synthesis 
 
An RNeasy Plus Mini Kit from Qiagen (Mississauga, ON, Canada) was used to 
purify mRNA from the ONS-76 cells.  To ensure high quality RNA for qRT-PCR array 
analysis, samples were analyzed by electrophoresis on an Agilent 2100 Series 
Bioanalyzer, Eukaryotic Total RNA Nano series II, version 2.0.  cDNA synthesis was 
performed on the extracted mRNA using the Quantitect Reverse Transcription Kit, also 
from Qiagen.  1 µg of template RNA at a time was converted to cDNA.   
 
2.5 qRT-PCR Arrays and PCR Confirmation 
 
Apoptosis and neurogenesis qRT-PCR arrays were purchased from 
SABiosciences (Frederick, MD, USA; array numbers PAHS-012 and PAHS-404, 
respectively).  The arrays contain primers for 84 gene transcripts involved in a either 
apoptosis or neurogenesis.  They also contain controls for genomic DNA contamination 
and reverse transcriptase efficiency.  The results from triplicate experiments were 
analyzed by using an SABiosciences online resource called RT2 profiler.  Confirmation 
of qRT-PCR array results involved the development of primers.  The primers were 
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designed using human mRNA gene sequences found on the NCBI human genome 
website (http://www.ncbi.nlm.nih.gov/projects/genome/guide/human/).  Sequences were 
copied and pasted into a website tool called Primer3 (http://frodo.wi.mit.edu/primer3/).  
Primer3 picks potential primers based on the input selection criteria chosen.  The criteria 
specified a product size between 180-300 base pairs, and a primer size between 18-23 
base pairs.  After designing, primers were purchased from Integrated DNA Technologies 
(IDT).  Primers for ATG5 and ATG7 were designed by Wu et. al (151), and primers for 
ATG6 and BCL2 were designed by Lian et al. (74).  qRT-PCR primer sequences for 
TrkA, Brn3a, and normalizer GAPDH are listed in the supplementary table S6 (143).  
Agilent Technologies’ Brilliant II SYBR Green QPCR Master Mix Kit (catalog number 
600828) was used to perform the qRT-PCR confirmation (in triplicate, also repeated 3 
times.  The PCR thermo-cycler used was a Stratagene Mx3005P model.  Cycle details are 
as follows and based on manufacturers suggestions: segment 1 had 1cycle, 10:00 minutes 
at 95oC; segment 2 had 40 cycles, the first at 95oC for 30 seconds, the second at 55oC for 
1 minute, and the third at 72oC for 1 minute; segment 3 had one cycle of 95oC for one 
minute, 55oC for 30 seconds and 95oC for 30 seconds. 
 
2.6 Kinome Analysis 
 
  ONS-76 cells were plated in sixteen, 250 ml 75 cm2 Falcon culture flasks at a 
concentration of 2.5x106 cells per flask.  The cells were allowed to adhere and recover 
overnight.  Twelve hours later, the cells were washed in 5 ml OptiMEM, then infected 
with either 2 ml diluted Adeno-Zhangfei or Adeno-LacZ at an MOI of 100 pfu/ml, or 
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mock infected.  The cells were then incubated at 37oC in the CO2 incubator for one hour, 
with rocking every 15 minutes.  After the hour, 10 ml of complete Dulbecco’s media (D-
MEM) was added.  At the time of harvest (48 hours post-infection) the supernatants were 
collected and centrifuged (10 minutes at 500 x g) to collect all cells that had lost 
adherence to the flask, and added to the remaining cells that were collected by 
trypsinization (with 2 ml of trypsin for 10 minutes) in the CO2 incubator.  The cells from 
each group (Adeno-LacZ and Adeno-Zhangfei) were then individually pooled and 
centrifuged for 10 minutes at 500 x g.  Supernatants were discarded and cell pellets were 
resuspended in 200 µl PBS.  Cells were collected, pelleted and lysed by addition of 100 
µl lysis buffer (20 mM Tris-HCL pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 
1% Triton, 2.5 mM sodium pyrophosphate, 1 mM Na3VO4, 1 mM NaF, 1 µg/ml 
leupeptin, 1 g/ml aprotinin, 1 mM PMSF), all products from Sigma-Aldrich, Ontario, 
Canada unless indicated.  Cells were lysed on ice for 10 minutes and the cell debris was 
pelleted in a microcentrifuge for 10 minutes at 4 ºC.  A 70 µl aliquot of the resulting 
supernatant was mixed with 10 µl of activation mix (50% Glycerol, 500 µM ATP (New 
England Biolabs, Pickering, Ontario, Canada), 60 mM MgCl2, 0.05% v/v Brij-35, 0.25 
mg/ml BSA), incubated on the array for 2 hours at 37 ºC.  Arrays were then washed with 
PBS containing 1% Triton.  Slides were submerged in phospho-specific fluorescent ProQ 
Diamond Phosphoprotein Stain (Invitrogen) with agitation for 1 hour.  Arrays were then 
washed three times in destain containing 20% acetonitrile (EMD Biosciences, VWR 
distributor, Mississauga, ON) and 50 mM sodium acetate (Sigma-Aldrich) at pH 4.0 for 
10 minutes.  A final wash was done with distilled deionized H2O.  Arrays were air-dried 
for 20 minutes then centrifuged at 300 x g for 2 minutes to remove any remaining 
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moisture from the array.  Arrays were analyzed using a GenePix Professional 4200A 
microarray scanner (MDS Analytical Technologies, Toronto, Ontario, Canada) at 532-
560 nm with a 580 nm filter to detect dye fluorescence.  Images were collected using the 
GenePix 6.0 software (MDS) and the spot intensity signal collected as the mean of pixel 
intensity using local feature background intensity background calculation with the default 
scanner saturation level. 
 The dataset contains the signal intensities associated with 300 peptides per array.  
ONS-76 cell groups (Zhangfei or LacZ-expressing) were collected in triplicate.  For each 
treatment, there were three intra-array replicates. 
The spot intensity of each peptide was calculated by subtracting background 
intensity from foreground intensity.  The resulting data were transformed using a variance 
stabilization (VSN) model.  The transformation brings all the data onto the same scale 
while alleviating variance-mean-dependence.  In addition, for each of the 300 peptides in 
a single treatment, the average was taken over the three transformed replicate intensities.  
Note that the averaging was only applied in the subsequent clustering analysis not in the 
statistical inferences.  Finally, the intensities induced by the treatments were adjusted by 
subtracting the intensities of the biological control (LacZ-expressing).  
 
2.7 Transcription Factor Profiling Array 
 
A transcription factor profiling array (Signosis BioSignal Capture, Sunnyvale, 
CA, USA) was used to determine which transcription factors were active in Adeno-
Zhangfei-infected cells, relative to Adeno-LacZ-infected cells.  This array measures the 
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ability of transcription factors to bind known DNA target sequences in the form of biotin 
labeled probes.  The probes are then separated from unbound probes and the transcription 
factors, then hybridized to complementary DNA sequences in a 96-well plate.  Results 
are produced by utilizing horse radish peroxidase conjugated streptavidin).  Cells were 
plated at 2 x 106 cells per well of a 6-well plate and infected at an MOI of 100 pfu/ml.  
Before the profiling array could be performed, the nuclear extracts from the ONS-76 cells 
were extracted with the use of the Signosis Nuclear Extraction Kit (Signosis).  Protocols 
from kits were followed according to the manufacturers specifications. 
 
2.8 Flow Cytometry and Fluorescent Microscopy 
 
Flow cytometry and fluorescent microscopy were performed to evaluate cellular 
death pathways both quantitatively and qualitatively.  Autophagy was detected by a Cyto-
ID autophagy detection kit (ENZO life sciences, Plymouth Meeting, PA, USA).  
Instructions for flow cytometry and fluorescent microscopy were followed as per 
manufacturers recommendations.  Detection of apoptosis by flow cytometry was 
performed with the use of an Annexin V staining kit (Calbiochem, VWR distributor 
Mississauga, Ontario, Canada).  Fluorescent microscopy was performed with the use of a 
dual stain apoptosis detection kit (Piscataway, NJ, USA).  Instructions for flow cytometry 
and fluorescent microscopy were followed as per manufacturers recommendations.  Flow 
cytometry was performed using a Coulter EPICS XL flow cytometer.   
Macropinocytotic vesicles were detected by fluorescent microscopy.  ONS-76 and 
D17 cells (Manassas, VA, USA) were plated at 2x105 cells per well in 6-well Falcon 
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plates, each containing an 18mm, 1-ounce micro cover slip (VWR).  Control cells were 
infected with Adeno-LacZ, treated cells received Adeno-Zhangfei, both at an MOI of 100 
pfu/ml.  24 hours later, the media was replaced with fresh media containing Alexa 488-
dextran (Invitrogen) at a concentration of 25 µg/ml.  24 hours later, the media was 
removed, 50 µl of it being replaced over the glass cover slips containing 10 nM of 
Lysotracker red (Invitrogen).  The cells were incubated for 10 minutes in the CO2 
incubator.  Next, the cells were washed 2 times with 100 µl of PBS.  Coverslips were 
inverted onto glass slides and sealed with clear nail polish.  Cells were examined 
immediately by fluorescent microscopy (Zeiss Axiovert, fitted with UV optics and CCD 
camera.  Images were captured and analyzed using Northern Eclipse software 
(Mississagua, Ontario, Canada). 
 
2.9 PC12 Cell NGF Sensitivity Assay 
 
PC12 cells grow neurites in the presence of NGF.  This assay was used to 
measure the approximate amount of NGF produced by ONS-76 cells (control, and 
Zhangfei-expressing).  24 hours after plating, the cells were treated with NGF 
(Cedarlane), goat anti-NGF (Cedarlane), NGF + anti-NGF, supernatant/cell lysate from 
ONS-76 cells expressing Zhangfei (250 µl), supernatant/cell lysate from ONS-76 cells 
expressing β-galactosidase (250 µl), or had the media replaced with fresh media and left 
as a control group.  Supernatant and cell lysate from ONS-76 cells was collected at 48 hpi 
using cell scrapers (BD Falcon) to lift adherent cells from the plate bottoms.  Next, the 
cell mixture was sonicated (Sonics and Materials, Danbury, CT, USA) for 5 seconds and 
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freeze-thawed 3 times to ensure all cells were lysed.  Next, the cell debris was removed 
by centrifugation at 600 x g for 5 minutes to remove large chunks of cellular debris.  
Supernatants were collected and stored at -80oC until use.  PC12 cells with and without 
neurites were counted by phase contrast microscope using a 25x objective, 72 hours after 
treatment. 
 
2.10 CAT Assay and Brn3a Promoter Plasmid Design 
 
A 2047 base pair region upstream of the Brn3a gene (containing the promoter 
region) was amplified using PCR from ONS-76 cellular genomic DNA.  The upstream 
primer (5ʹ′ GGTACCTAAAGACCAGCGCTTCCTTG 3ʹ′) contained Kpn1 restriction 
enzyme recognition site at its 5ʹ′ end.  The downstream primer (5ʹ′ CTCGAGGACGGGA 
TGCACTCCTCTAAC 3ʹ′) contains a Xho1 restriction enzyme recognition site on its 5ʹ′ 
end.  Restriction sites were used to facilitate cloning. The amplified 2047 base pair 
fragment was cloned using a TOPO cloning kit (Invitrogen).  Next, the fragment was 
transferred to pCAT3basic (Clontech) pCAT3basic is a chloramphenicol 
acetyltransferase (CAT) reporter plasmid. The resulting plasmid was named 
pCAT3bBrn3aPRO. 
ONS-76 cells were plated at 2.5 x 105 cells/ml, 2 ml per well in 6-well Falcon 
plates.  4 hours after plating, the cells were transfected using GeneJuice (EMD, VWR 
distributor).  GeneJuice transfections were optimized for ONS-76 cells to 6.5 µl of 
GeneJuice to 3.1 µg DNA total.  The protocol was followed as per manufacturers 
suggestions.  DNA concentrations for transfection were 0.1 µg of reporter plasmid 
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(pCAT3bATF6, pCAT3bBrn3aPRO), 0.5 µg pCMV-BGal, and 2.5 µg of pcDNA, 
pcLuS2210p, or pcZhangfei (pcZF) per tube.  After transfection, cells were incubated for 
48 hours in the CO2 incubator.  Next, CAT levels were measured using an ELISA kit 
(Roche Applied Science, Indianapolis, IN, USA).  The CAT assay was performed in 
triplicate for each test group.  Absorbance values for the CAT assay were measured at 
410 nm (reference 490 nm).  The entire experiment was repeated 2 more times to ensure 
reproducibility.  All CAT values were normalized for transfection efficiency using β-
galactosidase expression values.  β-galactosidase expression was detected by the addition 
of ortho-Nitrophenyl-β-galactoside (ONPG) substrate to cell lysates, resulting in the 
production of a yellow pigment that can be measured at 410 nm.  The amount of yellow 
pigment produced directly relates to the amount of β-galactosidase expressed in the cells, 
and therefore the transfection efficiency. 
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Chapter 3: Results 
 
3.1 Characterization of Zhangfei-Expressing Cells 
 
To confirm previous results that showed a marked decrease in the growth rate of 
Zhangfei-expressing ONS-76 cells (143), I examined the characteristics of these cells and 
cells expressing the control protein β-galactosidase (LacZ) utilizing adenovirus vectors as 
an expression system.  Figure 3.1(a) shows that ONS-76 cells expressing LacZ grew to 
confluency with very few floating cells 48 hours after infection.  The cells were epithelial 
in appearance as is characteristic of ONS-76 cells.  Zhangfei-expressing cells had a very 
different morphology.  At 48 hours, some cells remained attached to the culture dish, 
stopped dividing and grew neurite-like projections.  Other cells lost attachment to the 
substratum and rounded up.  By 96 hours post infection, almost all cells expressing 
Zhangfei had detached from the culture plate.  Figure 3.1(b) is a magnified view of the 
neurite-like projections produced by ONS-76 cells expressing Zhangfei. 
The growth rates of Zhangfei and LacZ-expressing cells were examined by 
staining them with WST-1.  In this assay, absorbance of the culture medium at 450 nm is 
an indication of cell number and viability (Figure 3.1c).  ONS-76 cells expressing 
Zhangfei exhibited a drastically reduced proliferation rate and viability.  Cells expressing 
the control protein continued to proliferate over 96 hours. 
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Figure 3.1. Characterization of Zhangfei-Expressing Cells.  ONS-76 cells were 
examined after infection with adenovirus vectors expressing either Zhangfei or the 
control protein LacZ.  (a)  Phase contrast micrographs showing morphology of ONS-76 
cells expressing either Zhangfei or LacZ.  Scale bar: 100 µm.  (b) Close-up of cell with 
neurite-like projections (arrow), 48 hpi with an adenovirus vector expressing Zhangfei.  
(c)  Proliferation of Zhangfei and LacZ-expressing cells over time.  Cells expressing 
Zhangfei or LacZ were stained with WST-1 on successive days after infection with 
adenovirus vectors and absorbance of the culture supernatant was measured. 
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3.2 Mechanisms of Cell Death 
 
3.2.1 Zhangfei-Mediated Apoptotic Death of ONS-76 Cells 
 
Cell death is characterized by oncosis or programmed cell death by apoptosis, 
autophagy, or macropinocytosis as reviewed by Edinger et al. and Overmeyer et al. (31, 
102).  To understand more about the mechanism by which Zhangfei activates cell death 
in ONS-76 cells, I examined cells 48 hours post infection (hpi) with Zhangfei or LacZ-
expressing adenovirus vectors for markers of apoptosis, autophagy and macropinocytosis. 
Phosphatidylserine exposure to the outer leaflet of the plasma membrane is a 
characteristic sign of apoptosis.  Annexin V is a cellular protein that has a binding affinity 
for phosphatidylserine.  Figure 3.2(a) shows the results of an Annexin V / propidium 
iodide staining experiment on ONS-76 cells expressing either Zhangfei or LacZ.  At 48 
hpi, 12.5% of cells expressing Zhangfei were pre-apoptotic and 3.4% of cells stained with 
propidium iodide and were considered to be dead (compared to LacZ-expressing cells at 
0.23% and 0.27% respectively).  
Analysis of apoptosis by fluorescent microscopy (Figure 3.2b) was performed 
using a Hoechst 33342 (blue) and propidium iodide (red) dual staining kit.  Hoechst 
33342 binds to DNA.  When bound to condensed chromatin, another characteristic of 
cells undergoing apoptosis, it fluoresces more brightly.  Propidium iodide is only 
permeable to dead cells.  Cells could be divided into three groups based on their staining 
characteristics: alive, dead, or apoptotic.  Three cell groups have been stained in Figure 
3.2(b): β-galactosidase expressing cells which showed little variance in Hoechst 33342  
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Figure 3.2. Zhangfei-Mediated Apoptotic Death of ONS-76 Cells.  ONS-76 cells were 
examined 48 hpi with adenovirus vectors expressing either Zhangfei or LacZ.  (a)  
Annexin V and propidium iodide staining of ONS-76 cells expressing either Zhangfei or 
control protein LacZ analyzed by flow cytometry (n = 3).  Cells were grouped based on 
viability: preapoptotic or dead.  Preapoptotic and dead cells are displayed in the figure 
based on percent of total cells (alive and dead).  Error bars represent standard deviation.  
(b)  Chromatin condensation analysis by fluorescence microscopy.  Hoechst 33342 (blue) 
stains condensed DNA more brightly than uncondensed DNA.  Propidium iodide (red) is 
permeable only to dead cells.  Scale bar: 100 µm.  
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staining and contained few dead cells, Zhangfei-expressing cells (attached to the 
substratum) showing more dead and apoptotic cells than the control, and Zhangfei-
expressing cells that have lost attachment to the substratum, which present with many 
dead cells and some apoptotic cells. 
 
3.2.2 Zhangfei-Mediated Autophagic Death of ONS-76 Cells 
 
Flow cytometry staining for autophagy was performed with the use of Cell-ID 
(green) stain (Figure 3.3a).  Cell-ID stains autophagic vesicles.  Tamoxifen was used as a 
positive control.  Tamoxifen works by increasing intracellular ceramide levels and 
abolishing the inhibitory effect of class-I phosphoinositide 3ʹ′-kinase (PI3K) (124).  
Zhangfei expression in ONS-76 cells increased the X-mean (average Cell-ID 
fluorescence of the population of cells) by approximately 2-fold.  Tamoxifen increased 
the X-mean by approximately 2.5-fold. 
Fluorescent microscopy was performed using the Cell-ID stain, in conjunction 
with Hoechst 33342, Figure 3.3(b).  Tamoxifen treated cells had bright green, peri-
nuclear staining of autophagosomes.  ONS-76 cells expressing LacZ had relatively few, 
small autophagosomes.  Cells expressing Zhangfei were divided into 2 groups, cells that 
remained attached to the substratum at 48 hours, and cells that were floating.  Many 
floating cells showed a fragmented nucleus (as seen by Hoechst 33342 staining), and 
large autophagosome compartments.  Some attached, Zhangfei-expressing cells also 
displayed a fragmented nucleus, and interestingly, the entire cytoplasm stains a faint 
green.  These cells failed to exhibit numerous large autophagic vesicles.   
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Figure 3.3. Zhangfei-Mediated Autophagic Death of ONS-76 Cells.  ONS-76 cells 
were examined 48 hpi with adenovirus vectors expressing either Zhangfei or LacZ.  (a)  
Cell-ID (green) staining of ONS-76 cells expressing either Zhangfei or LacZ analyzed by 
flow cytometry (n = 3).  Cell-ID stains mature autophagic vesicles.  X-mean refers to the 
average fluorescence of the entire population of cells.  Tamoxifen, a chemical inducer of 
autophagy, was used as a positive control.  A Kruskal-Wallis test of all three samples 
yielded a significance of >0.05.  Mann-Whitney tests between treatment groups yielded 
significance values of >0.05.  Error bars represent standard deviation.  (b)  Cell-ID and 
Hoechst 33342 staining of ONS-76 cells by fluorescent microscopy.  Hoechst 33342 is 
used as a nuclear counter stain. Scale bar: 50 µm.  
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3.2.3 Zhangfei-Mediated Macropinocytotic Death of ONS-76 Cells 
 
Macropinocytosis as a death pathway is characterized by the accumulation of 
many, large vacuoles consisting of extracellular fluids (102).  To test Zhangfei-expressing 
ONS-76 cells for these vacuoles, the cells were stained with Alexa 488-dextran (green) 
and Lysotracker (red).  Alexa 488-dextran supplemented in the media is taken up by cells 
during the normal process of macropinocytosis.  If the macropinocytosis pathway is 
overactive, Alexa 488-dextran accumulates in enlarged vacuoles, while lysotracker red 
will stain lysosomes.  D17 dog osteosarcoma cells were used as a positive control as they 
express many, large extracellular-fluid filled vesicles when they express Zhangfei 
(manuscript in preparation).  Figure 3.4 shows that, as expected, the positive control D17 
cells produced large extracellular-fluid filled vacuoles.  LacZ-expressing ONS-76 cells 
had a few, small macropinosomes, some associated with lysosomes.  Zhangfei-expressing 
ONS-76 cell (both floating and attached) also expressed macropinosomes, but unlike the 
Zhangfei-expressing D17 cells, they were small and appeared to be part of the “normal” 
cellular substructure. 
 
3.3 Molecular Effects of Zhangfei 
 
3.3.1 Zhangfei-Induced Transcription 
 
Due to the observed involvement of Zhangfei in the processes of apoptosis, 
autophagy, and neurogenesis, qRT-PCR was performed to assay genes affected by  
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Figure 3.4. Zhangfei-Mediated Macropinocytosis in ONS-76 Cells.  48 hpi with 
adenovirus vectors expressing either Zhangfei or LacZ, ONS-76 cells were stained for 
macropinosome and lysosome expression.  Alexa 488-dextran staining of ONS-76 cells 
expressing either Zhangfei or LacZ by fluorescent microscopy.  D17 cells were used as a 
positive control as they produce large extracellular-fluid filled vesicles when they express 
Zhangfei. Scale bar: 100 µm.  Magnified images are in insets. 
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Zhangfei in these three areas.  To determine which cellular differentiation and apoptotic 
genes Zhangfei might activate in ONS-76 cells, two quantitative real time polymerase 
chain reaction (qRT-PCR) arrays were performed.  These arrays contain 84 primer pairs 
for genes involved in apoptosis or neurogenesis.  A 4-fold increase/decrease in gene 
transcript and a P-value of 0.05 or less were used to exclude transcripts that may be too 
low in statistical significance. The array results were subject to confirmation using qRT-
PCR with primers designed in-lab.   
Results from the Neurogenesis array (Figure 3.5a, top panel) indicated a number 
of gene transcripts were upregulated post-Zhangfei expression.  These genes (indicated 
from most-to-least upregulated) included: amyloid beta precursor binding protein 1 
(APBB1), epidermal growth factor (EGF), disk large homolog 4 (DLG4), bone 
morphogenic protein 8 B (BMP8B), S100 calcium binding protein B (S100B), and 
anaplastic lymphoma receptor tyrosine kinase (ALK).  Glial cell derived neurotrophic 
factor (GDNF) was the only downregulated transcript.  RT-PCR confirmation (figure 
3.5a, bottom panel) ensured the qRT-PCR array results.  
Results from the apoptosis array (Figure 3.5b) indicated that gene transcripts: 
tumor necrosis factor receptor superfamily member 9 (TNFRSF9), tumor necrosis factor 
receptor superfamily member 5 (CD40), and tumor necrosis factor (TNF) were 
upregulated.  Gene transcripts down-regulated greater than a fold-change value of 4 
include: caspase family member 1 (CASP1), and cell death-inducing DFFA-like effector 
A (CIDEA).  Following qRT-PCR array analysis, qRT-PCR confirmation of the 
upregulated and downregulated gene transcripts using independently designed primers  
 
	   46	  
  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5.  Zhangfei-Induced Transcription.  48 hours post-adenovirus infection, 
ONS-76 cells were assayed for gene transcript level changes in the areas of neurogenesis, 
apoptosis, and autophagy.  Zhangfei-expressing cells were examined relative to control 
protein (LacZ) expressing cells.  Each array was repeated three times and the results are 
shown as an average of the three.  P-values for all transcripts listed (tested by qRT-PCR 
array, figures (a) and (b), upper portion) are all below 0.05 and are listed in the 
supplementary data (S1 and S2).  P-values: **** (<0.0001), *** (<0.001), ** (<0.01), * 
(<0.05).  A confirmation of gene transcript from the array displaying a fold change of 
greater than 4 and a P-value of less than 0.05 was performed using primers designed in-
lab (n = 3).  Results from the confirmation are listed directly below the array data.  Bars 
represent standard deviation.  (a)  Neurogenesis cDNA array.  qRT-PCR analysis of gene 
transcripts affected by Zhangfei expression.  (b)  Apoptosis cDNA array.  qRT-PCR 
analysis of gene transcripts affected by Zhangfei expression.  (c)  qRT-PCR analysis of 
autophagy response genes: autophagy related 5 homolog (ATG5), Beclin 1 (ATG6), 
autophagy related 7 homolog (ATG7), and the autophagy regulator / pro-survival gene B-
cell CCL/lymphoma 2.  Fold change in transcript levels were measured 48 hpi in 
Zhangfei and LacZ-expressing cells.  Each qRT-PCR experiment was performed 3 times, 
each experiment measuring gene expression in triplicate.  Bars represent standard 
deviation. 
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was performed to confirm array accuracy.  Results of this qRT-PCR confirmation are 
depicted in the bottom portion of Figure 3.5(b).  The confirmation of the array data 
affirms the array’s results in all but one transcript, CIDEA.  CIDEA transcript was 
downregulated according to the apoptosis qRT-PCR array, and upregulated in the qRT-
PCR confirmation.  As such, CIDEA was excluded from this point forward.  A list of all 
genes involved in the qRT-PCR arrays along with fold change and P-values is in the 
supplementary data sections S1 and S2 of this thesis. 
To determine the effect of Zhangfei expression on autophagy-related gene 
transcripts, primers were designed for autophagy related 5 homolog (ATG5), Beclin 1 
(ATG6), autophagy related 7 homolog (ATG7), and the autophagy regulator gene B-cell 
CCL/lymphoma 2 (BCL2).  These genes were chosen as each plays a role in the different 
stages of autophagy.  All three autophagy response genes were upregulated (measured by 
qRT-PCR) in response to Zhangfei (relative to LacZ-expressing ONS-76 cells), and pro-
survival BCL2 (an inhibitor of autophagy, 106) transcript was downregulated, Figure 
3.5(c).  These data in combination with the absence of numerous, large autophagic 
vesicles in Zhangfei-expressing cells led to the conclusion that autophagy did not appear 
to be the primary mechanism of cell death in these cells, but rather, a natural part of cell 
death. 
 
3.3.2 Kinome Analysis 
 
To determine which protein kinase signaling cascades are active in Zhangfei-
expressing ONS-76 cells, a kinome analysis was performed.  Results for Zhangfei-
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expressing cells were compared to LacZ-expressing cells.  It should be noted that the 
kinome array used in this experiment was originally designed for characterizing immune 
responses, so the kinase targets tested were biased towards these processes.  Only peptide 
phosphorylation values with a P-value of 0.05 or less would continue on to pathway 
analysis by InnateDB software.  InnateDB is an online software program that inputs 
peptide phosphorylation values and predicts potential kinome cascades that are active or 
inactive within a group of cells.  Table 3.6(a) shows the results of such a kinome analysis 
by InnateDB.  Only kinase cascade pathways with a P-value of 0.025 or less are 
displayed.  The top 4 molecular pathways predicted to be activated by Zhangfei 
expression in ONS-76 cells are: the JNK (JUN N-terminal kinase) cascade, MAPK 
(mitogen activated protein kinase) signaling cascade, TGFβ (transforming growth factor 
beta) signaling cascade (via TAK1, nuclear receptor subfamily 2, group C, member 2), 
and p53 (tumor protein 53) direct effector proteins. Table 3.6(b) lists the kinases that are 
known to be involved in each pathway.  It should be noted that all pathway members 
corresponding to the JNK and TGFβ pathways are also represented in the MAPK 
signaling pathway.  Explanations for this may be that kinase cascades often have a great 
deal of crosstalk, or that the implied activation of a pathway may simply be an artifact of 
the activation of another pathway with similar members.  A supplementary table 
including all kinase targets tested, fold change in phosphorylation values, and P-values 
can be viewed in the supplementary data sections S7 and S8. 
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Table 3.6. Kinome Analysis.  Kinome analysis involves measuring the phosphorylation 
status of key members of kinase signaling cascades.  48 hpi with adenovirus vectors 
expressing either Zhangfei or LacZ, ONS-76 cells were harvested for this analysis.  (a)  
Kinase cascades active in ONS-76 cells expressing Zhangfei.  All results are a 
comparison between Zhangfei-expressing cells and β-galactosidase (control protein) 
expressing cells (n = 3).  Database refers to the number of protein members in the 
corresponding molecular pathway that are uploaded into the InnateDB software program.  
The “up” and “down” arrows refer to the number of pathway members that have 
experienced a fold increase or decrease in phosphorylation.  The corresponding P-values 
refer to the probability that the given pathway is or is not upregulated due to the treatment 
(Zhangfei expression).  Only pathways with a P-value of 0.025 or lower are listed in 
Table 3.6(a).  (b) Table 3.6(b) contains the affected individual members of the pathways 
listed in Table 3.6(a).  
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3.3.3 Transcription Factor Profiling Array 
 
Transcription factors usually represent the end-effectors of signaling cascades and 
directly regulate the transcription of target genes.  Using the transcription factor profiling 
array, I tested for the activation of 48 well-known transcription factors and compared the 
results relative to a control set of cells (LacZ-expressing cells).  The results listed in this 
section (Figure 3.7) include only transcription factors activated, or less active by a value 
greater than 1.5 fold.  Activated transcription factors (from most to least activated) 
include: brain-specific homeobox/POU domain protein 3A (Brn3a), signal transducer and 
activator of transcription 6, interleukin-4 induced (Stat6), transcription factor AP2 (AP2), 
cyclic-AMP response element binding protein (CREB), activator protein 1 (AP1), 
CCAAT-box-binding transcription factor zeta (CBF), v-myc myelocytomatosis viral 
oncogene homolog associated factor X (Myc-Max), androgen receptor (AR), tumor 
protein 53 (p53), forkhead box H1 (FAST-1), interferon regulatory factor (IRF), myelin 
expression factor 2 (Mef-2), nuclear factor kappa B (NFκB), early growth response 1 
(EGR), and transcription factor Sp1 (Sp1).  Transcription factors found to be less active 
in Zhangfei-expressing cells include SATB homeobox 1 (SATB1) and serum response 
element (SRE) binding factors.  A full list of transcription factors included in this array, 
along with fold activation values can be viewed in the supplementary materials provided 
(S9). 
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Figure 3.7. Transcription Factor Profiling Array.  Fold activation of transcription 
factors in response to infection of ONS-76 cells by Adeno-Zhangfei as determined by the 
Signosis transcription factor profiling array (n = 1).  15 of 48 transcription factors in the 
array displayed a fold activation of greater than 1.5, these are displayed in the figure 
above.  Brn3a displayed the highest value at a 2.4 fold increase in activity. A complete 
list of transcription factors involved in the array can be viewed in supplementary table S9.  
Transcription factors with a fold deactivation in activity of less than -1.5, these are 
SATB1 and SRE.  SATB1 displayed the lowest value at a 2.7 fold decrease in activity. 
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3.4  Zhangfei, Brn3a, and TrkA: Proposing a Molecular Pathway for the Effects of  
       Zhangfei 
 
Based on the results of the cDNA arrays, kinome analysis, transcription factor 
profiling array, and previous results in our laboratory showing an increase in the 
expression of TrkA following the expression of Zhangfei (142), a model is proposed for 
the molecular mechanism by which Zhangfei may affect ONS-76 cells in Figure 3.8(a).  
Based on the results of the transcription factor profiling array, Zhangfei upregulates the 
activity of transcription factor Brn3a.  Currently, Zhangfei is not known to bind any 
identified DNA bZIP protein recognition sites, although it may do so in conjunction with 
other bZIP proteins (52).  Brn3a is known to regulate the expression of TrkA (80, 142).  
Without Zhangfei expression, TrkA expression is undetectable in ONS-76 cells.  
Expression of TrkA could sensitize the system to NGF stimulation, resulting in MAPK 
signaling (one of the top signaling pathways activated in ONS-76 cells expressing 
Zhangfei, according to the kinome analysis).  Next, TrkA signaling could trigger the 
activity of downstream transcription factors and other signaling pathways that ultimately 
lead to the death of the ONS-76 cells.  I understand that other signaling pathways may 
play a role in this process, but have chosen to focus in on the effects of TrkA signaling, 
since this offers a plausible explanation for my results.   
To confirm previous results in our laboratory that TrkA transcript levels increased 
following Zhangfei expression in ONS-76 cells (143), primers were designed to test for 
TrkA transcript changes using qRT-PCR.  Primers were also designed to determine  
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Figure 3.8.  Zhangfei, Brn3a, and TrkA: Proposing Molecular Pathway for the 
Effects of Zhangfei.  (a)  Proposed molecular pathway for the effects of Zhangfei.  A 
simple diagram proposing how Zhangfei may initiate cell death in ONS-76 cells.  The 
expression of Zhangfei in ONS-76 cells mediates (perhaps with the help of another bZIP 
protein) the expression of Brn3a.  Brn3a is a transcription factor known to be capable of 
inducing the expression of TrkA.  I believe that TrkA signaling stimulated by autocrine 
NGF brings about cell death in ONS-76 cells by the activation of apoptosis with 
accompanying autophagy as a part of the natural death process.  (b)  qRT-PCR analysis 
of TrkA and Brn3a transcript levels (fold change), 48 hpi with adenovirus vectors 
expressing either Zhangfei or LacZ (n = 3).  (c)  The effect of Zhangfei expression on 
Brn3a promoter activation.  A 2 kb region upstream of the Brn3a gene was isolated and 
cloned into a CAT expression plasmid.  Next, pcZF (Zhangfei coding region cloned into 
pcDNA), pcATF4 (ATF4 coding region cloned into pcDNA) or a control plasmid 
(pcDNA) were co-transfected into ONS-76 cells.  48 hours after transfection, CAT 
expression levels were measured.  Transfection efficiency was normalized using a β-
galactosidase expressing plasmid.  Zhangfei was consistently able to induce transcription 
from the Brn3a promoter by ~2 fold.  The CAT assay results are an average of 3 assays, 
each containing intra-experimental duplicates.  Results are displayed as fold change 
(CAT activation / CAT value for pcDNA). 
 
 
 
 
	   54	  
relative levels of the Brn3a transcript.  cDNA from ONS-76 cells expressing either 
Zhangfei or LacZ was collected 48 hpi.  Brn3a was tested because it was the most 
upregulated transcription factor (by activity) according to the transcription factor 
profiling array (and a vital part of the proposed hypothesis).  The results of qRT-PCR 
testing of these transcripts can be seen in Figure 3.8(b).  TrkA transcript was upregulated 
by ~18 fold in Zhangfei-expressing cells, and Brn3a by ~26 fold. 
Next, I explored the mechanism by which Zhangfei activates the expression of 
Brn3a.  A 2 kb region upstream of the Brn3a gene was isolated and cloned into a CAT 
reporter plasmid.  By measuring CAT expression with and without a co-expression of 
Zhangfei, the ability of Zhangfei to activate Brn3a transcription could be quantified.  
Results indicate that Zhangfei successfully and consistently increased transcription from 
the Brn3a promoter by 2.2 +/- 0.28 fold (Figure 3.8c).  Co-expression of Brn3a promoter-
CAT reporter (pCAT3bBrn3aPRO) and pcATF4, a plasmid expressing another bZIP 
containing protein, activating transcription factor 4 resulted in an increase of 1.38 +/- 
0.20 fold.  On its own, ATF4 was not able to activate transcription from the Brn3a 
promoter.   
 
3.5 Nerve Growth Factor Production by ONS-76 cells 
 
To substantiate the hypothetical pathway proposed in Figure 3.8(a), an 
investigation into key nodes of the pathway was initiated.  NGF stimulation is 
characteristically the initiating step in TrkA signaling.  Since it does not appear that NGF 
is highly upregulated in Zhangfei-expressing cells, a NGF bioassay was performed using 
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PC12 cells to test for NGF production.  In the presence of NGF, PC12 cells grow 
neurites. The number of PC12 cells expressing neurites is roughly proportional to the 
amount of NGF administered (Figure 3.9a).  ONS-76 supernatant was collected at 48 hpi 
with adenovirus vectors expressing either Zhangfei or LacZ.  Anti-NGF antibody was 
used to neutralize the effects of NGF.  As seen in Figure 3.9(b), anti-NGF antibody was 
successful in reducing the number of PC12 cells producing neurites in all three test 
groups by approximately 50%.  Control refers to PC12 cells receiving 50 ng/ml NGF. 
PC12 cells receiving supernatant from LacZ-expressing cells had more cells with neurites 
than PC12 cells receiving supernatant from Zhangfei-expressing cells.  This is not 
surprising, as by 48 hpi, Zhangfei-expressing cultures have much fewer cells than LacZ-
expressing cultures, and are not actively proliferating.   
A WST-1 proliferation and viability stain was performed on ONS-76 expressing 
Zhangfei or LacZ 48 hpi, as in Figure 3.9(c), but this time the growth media was 
supplemented with anti-NGF.  Figure 3.9(c) shows how anti-NGF was able to partially 
restore the viability of ONS-76 cell, presumably by neutralizing the effects of NGF 
signaling. 
 
3.6 The Effect Chemical Inhibitors on the Viability of ONS-76 Cells Expressing  
      Zhangfei 
 
A WST-1 proliferation and viability assay was performed on ONS-76 cells 
expressing Zhangfei or LacZ 48 hpi (Figure 3.10).  This time, the cells were given a 
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Figure 3.9. NGF Production by ONS-76 Cells.  In the presence of NGF, PC12 cells 
grow neurites.  PC12 cells were given supernatant from Zhangfei-expressing or LacZ-
expressing ONS-76 cell cultures (48 hpi), as well as 50 ng/ml NGF as a positive control.  
Treatments were given with or without anti-NGF.  Cells expressing neurites were counted 
in 10 random microscope fields at 25x objective.  Anti-NGF antibody was used to 
neutralize the effects of NGF.  (a)  PC12 cell neurite growth response NGF.  The bar 
graph created reflects the percentage of PC12 cells expressing neurites in response to 
various known amounts of NGF.  The number of cells expressing neurites is proportional 
to the amount of NGF administered.  (b)  Neutralizing the effects of NGF.   Anti-NGF 
antibody was able to greatly reduce the number of neurite producing cells in all three 
PC12 cell test groups (Zhangfei supernatant, LacZ supernatant, and 50 ng/ml NGF), (n = 
3).  P-values: * (< 0.05). ** (< 0.005), *** (< 0.0005).  Statistical differences between 
samples were calculated using Student T-test.  Error bars represent standard deviation.  
(c)  Neutralization of NGF increased the viability of ONS-76 cells expressing Zhangfei.  
48 hpi with adenovirus vectors expressing Zhangfei or LacZ a WST-1 staining was 
performed to assess the viability of these cells.  Absorbance at 450 nm indicated that anti-
NGF was able to partially restore the viability of Zhangfei-expressing ONS-76 cells, and 
have little-to-no effect on control cells.  P-value: * (<0.05). Statistical differences 
between samples were calculated using Student T-test.  Error bars represent standard 
deviation. 
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range of chemical inhibitors or left untreated as a control.  This list of inhibitors selected 
for the analysis was based on the results of the transcription factor profiling array, kinome 
analysis, and work done by other researchers in the field of apoptosis and autophagy.  
Inhibitors used include: JNK inhibitor (i) (SP600125, 25 µM), p53i (Pifithrin alpha, 25 
µM), Meki (PD98059, 50 µM), CK1i (D4476, 40 µM), apoptosis I (M50054, 420 µM), 
TrkAi (EMD TrkA inhibitor, 25 µM), and an ERKi (ERK inhibitor #2, EMD, 25 µM).  A 
list of concentrations and scientific names is included in the materials and methods 
section (Table 2.1).  The chemical inhibitors were being used in an attempt to ablate the 
death signaling occurring after expression of Zhangfei. 
Most of the inhibitors also suppressed the growth of LacZ-expressing cells.  For 
this reason, instead of displaying absolute absorbance values, the results were expressed 
as a ratio of absorbance of LacZ:Zhangfei-expressing cells, assuming that the toxic 
effects of the inhibitors would be the same for both cells. The ratio for untreated cells was 
about 2.  If an inhibitor were able to completely counteract the effects of Zhangfei, the 
ratio would be 1. Inhibitors with ratios that were significantly different from untreated 
cells were JNK, MEK, and TrkA.  These results suggest that JNK, MEK, and TrkA 
signaling play a role in Zhangfei-mediated cell death. 
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Figure 3.10.  The Effect of Chemical Inhibitors on the Viability of ONS-76 Cells 
Expressing Zhangfei.  After treating Zhangfei and LacZ-expressing cells with chemical 
inhibitors of select kinases, a WST-1 assay was performed at 48 hpi.  Ratios between 
Zhangfei-expressing and LacZ-expressing absorbance values were taken, and the 
experiment was performed four times (n = 4).  Ratios were used to display the results of 
inhibitors that were able to bring the viability of cells expressing Zhangfei to the level of 
cells expressing LacZ.  Therefore, inhibitor groups with ratios closest to 1 were able to at 
least partially restore the viability of Zhangfei-expressing cells.  The JNK, MEK, and 
TrkA inhibitors met this criterion with reasonable consistency. P-values: * (< 0.05). ** (< 
0.005), *** (< 0.0005).  Error bars represent standard deviation. 
 
 
 
 
 
 
 
	   59	  
Chapter 4:  Discussion 
 
4.1 Proposed Mechanism of Zhangfei-Induced Cell Death 
 
4.1.1 Introduction 
 
 Signaling through the high-affinity nerve growth factor receptor, TrkA, is 
known to play a major role in the maintenance, survival, and development of sensory 
neurons (6, 54, 105, 128).  There is evidence, however, that TrkA signaling can also play 
a role in the induction of cell death in neuronal tumors such as neuroblastoma and 
medulloblastoma.  Three cellular death pathways that appear to be activated by TrkA in 
these neuronal tumors emerge in the literature: apoptosis, autophagy, and 
macropinocytosis (48, 72, 118).  
   
4.1.2  Zhangfei Activates Apoptotic Cell Death With Accompanying Autophagy 
 
 Results of the fluorescent staining of ONS-76 cells expressing Zhangfei indicated 
a lack of numerous large macropinosomes (Figure 3.4), a feature characteristic of death 
brought upon by overactivation of macropinocytosis (72).  As such, I concluded that 
Zhangfei did not overactivate macropinocytotic pathways.  In addition to a lack of 
macropinosomes, Zhangfei-expressing cells failed to produce large, mature, perinuclear 
autophagosomes, a characteristic of cells undergoing autophagy as a death pathway (48).  
Zhangfei expression did however, increase staining of autophagic vesicles (by flow 
	   60	  
cytometry, Figure 3.3a) and the expression of autophagy response genes ATG5, ATG6, 
and ATG7.  These results led me to conclude that Zhangfei did not overactivate 
autophagic pathways in ONS-76 cells, but rather, autophagy occurred as a consequence 
of cell death induced by other mechanisms.  The analysis of apoptosis was different.  
Expression of Zhangfei increased the amount of phosphatidylserine exposed to the outer 
leaflet of the plasma membrane (a key sign of apoptosis, Figure 3.2) in a portion of cells.  
Many of these cells also stained in higher amounts for condensed chromatin, another sign 
that apoptosis had occurred.  In addition to these results, Zhangfei upregulated apoptotic 
response genes: TNFRSF9 (4-1BB, CD137), CD40 (TNFRSF5), and TNF (Figure 3.5b).  
TNFRSF9 is generally expressed in activated T-cells, B-cells, macrophages and dendritic 
cells (16, 28).  Information on TNFRSF9 signaling is scarce, but it has been shown to 
link to JNK signaling (16), the most likely kinase cascade active in Zhangfei-expressing 
ONS-76 cells, predicted by the kinome analysis (Table 3.6a).  CD40 is also known to be 
present on antigen-presenting cells, and is linked to JNK signaling (130, 149).  The role 
of these membrane receptors, generally requiring activation by interaction with other 
immune cell ligands, remains unknown in these ONS-76 cells for the time being.  In 
contrast, the role of TNFα in inducing apoptosis has been well documented (112).  Two 
receptors for TNF exist, TNF-R1 and TNF-R2.  TNF-R1 is expressed in most cell types, 
while TNF-R2 is limited to immune cells.  TNF-R1 signaling is generally involved in 
apoptotic signaling, including cell death mediated by the JNK signaling pathway (19, 40).   
  Although Figure 1.3 (Literature Review) lists caspase 3 as a chief convergence 
point in the activation of all apoptotic events, caspase 3 transcripts were not found to be 
actively upregulated in Zhangfei-expressing cells.  However, this may not be essential as 
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caspases exist as translated procaspases within the cell, and are activated by proteolytic 
cleavage.  There have been studies however, that explore apoptosis in the absence of 
caspase 3 activation.  Notably, Didenko et al. describe a situation in which TGFβ 
signaling leads to apoptosis in the absence of caspase 3 (14).  Interestingly, TGFβ 
signaling was predicted to be one of the possible kinase cascades active in Zhangfei-
expressing cells (Table 3.6a).  TGFβ signaling may provide an explanation for the 
observation of caspase 3-independent apoptosis as well.  In regards to autophagy 
accompanying apoptosis, there are many documented cases of these processes occurring 
in parallel (7, 27, 31, 71, 81).  
 
4.2  Zhangfei and Neuronal Differentiation 
 
When Zhangfei was expressed in ONS-76 cells, the cells stopped dividing and 
grew projections resembling neurites (visible at 48 hpi, Figure 3.1a, Figure 3.1b).  By 96 
hpi, most of the Zhangfei-expressing cells were dead.  In contrast, cells expressing the 
control protein LacZ grew to confluency.  I hypothesized that TrkA expression was at 
least partly responsible for the growth of the neuronal projections as TrkA signaling has 
been shown to play a major role in the differentiation and development of neurons (see 
section 1.1.6 of the Literature Review).  In addition to stimulating the growth of neurite-
like projections, Zhangfei was also able to increase the expression of genes involved in 
neurogenesis.  These genes included: amyloid beta (A4) precursor binding protein 
(APBB1, FE65), epidermal growth factor (EGF), disks large homolog 4 (DLG4), bone 
morphogenic protein 8b (BMP8B), S100 calcium binding protein B (S100B), and 
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anaplastic lymphoma receptor tyrosine kinase (ALK).  APBB1 is an adapter protein for 
APP (amyloid precursor protein) and is involved in regulating APP-induced transcription, 
DNA damage responses, upregulating apoptosis, and in neurite genesis (97).  Sabo et al. 
have shown APBB1 and APP to localize in neurite growth cones of neurites and suggest 
that these proteins play a role in cell movement and neurite growth (120).  EGF is a 
signaling molecule.  Like NGF, EGF signaling also triggers MAPK pathway signaling.  
Unlike NGF signaling, EGF signaling is not usually recognized for inducing neurite 
growth, although Mark et al. have shown EGF and potassium chloride treatment of PC12 
cells to stimulate neurite growth (85).  Traverse et al. have also described a system in 
which EGF treatment of PC12 cells that overexpress the EGF receptor undergo 
differentiation (138).  DLG4 interacts with other DLG proteins to form multimeric 
scaffolds to link ion channels and receptors (78).  Although the effects of BMP8b have 
not been heavily studied, the BMP family of proteins are known to be highly involved in 
neuronal development and differentiation (88).  S100B is a known negative regulator of 
p53, a tumor suppressor protein found to be upregulated in activity by the transcription 
factor profiling array (Figure 3.7).  S100B has been shown to either promote neurite 
growth and cellular survival or promote apoptosis in a dose dependent manner (117).  
S100B is generally secreted by glial cells, targeting neurites.  S100B secretion may 
represent the bipotential differentiation of ONS-76 cells to both neuronal and glial cells.  
ALK is a tyrosine receptor kinase, like TrkA.  It is expressed in the developing central 
and peripheral nervous system.  Expression of constitutively active ALK in PC12 cells 
resulted in neurite growth and differentiation in a MAPK signaling pathway dependent 
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manner (43).  Altogether, these results support the hypothesis that Zhangfei activates 
neuronal differentiation in ONS-76 cells. 
 
4.3  Molecular Mechanisms Executing the Effects of Zhangfei 
 
Based on results obtained, a mechanism was proposed by which Zhangfei may 
activate apoptosis in ONS-76 medulloblastoma cells with autophagy accompanying cell 
death as a natural process.  In this model (Figure 3.8a) Zhangfei induces the expression of 
transcription factor Brn3a, resulting in the transcription of TrkA.  A modified version of 
this figure is repeated below (Figure 4.1).  Figure 4.1 lists signaling pathways thought to 
be upregulated in Zhangfei-expressing cells, and my evidence supported each pathway.  
Zhangfei was able to induce expression from a CAT expression plasmid containing the 
Brn3a promoter, by approximately 2 fold (Figure 3.8c).  Brn3a transcriptional activity 
was increased by approximately 2.5 fold in Zhangfei-expressing cells according to a 
transcription factor profiling array (Figure 3.7c).  Brn3a has been proposed as a 
transcription factor capable of influencing TrkA expression (80, 141).  Expression of both 
Brn3a and TrkA transcript increased by approximately 25 and 20 fold in Zhangfei-
expressing ONS-76 cells, respectively (Figure 3.8b).   
 According to the kinome analysis, the TrkA (MAPK signaling pathway), was one 
of the top-four predicted signaling pathways likely to be active in Zhangfei-expressing 
ONS-76 cells (Table 3.6a).  Initiation of MAPK signaling involves binding of NGF to the 
TrkA receptor.  ONS-76 cells were found to produce NGF regardless of the expression of 
Zhangfei (ie. both control protein and Zhangfei-expressing ONS-76 cells produced NGF,  
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Figure 4.1.  Molecular Mechanisms Executing the Effects of Zhangfei.  Activation of 
MAPK and JNK Signaling Pathways by Zhangfei.  Expression of Zhangfei in ONS-76 
cells results in the transcription of Brn3a and TrkA.  Zhangfei increased expression from 
the Brn3a promoter by approximately 2-fold.  Brn3a, as a transcription factor, has been 
shown to actively upregulate TrkA expression.  Activation of TrkA has been shown to 
increase both MAPK and JNK signaling pathways.  The table listed in the figure gives 
experimental support to the activation of these signaling pathways in ONS-76 cells 
expressing Zhangfei. 
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Figure 3.9).  LacZ-expressing cultures were found to produce more NGF than Zhangfei-
expressing cells at 48 hpi with adenovirus vectors.  This is not surprising as Zhangfei-
expressing cells appeared to stop dividing immediately following Adeno-Zhangfei 
infection, while Adeno-LacZ-infected cells continued to multiply and reach a high 
density.  Neutralization of NGF in the media of Zhangfei-expressing cells also increased 
the viability of these cells at 48 hpi (Figure 3.9c).  This further supports the hypothesis 
that the TrkA pathway is activated in Zhangfei-expressing cells by autocrine NGF 
stimulation.  Activation of the MAPK signaling pathway by TrkA-NGF interactions may 
lead to the activation of transcription factors c-Fos (cellular oncogene fos) and c-Jun (Jun 
activation domain binding protein), collectively known as AP-1.  AP-1 transcriptional 
activity was found to be upregulated in Zhangfei-expressing cells. 
 After prolonged activation, TrkA is endocytosed and continues to signal. This 
process is termed retrograde signaling (Figure 1.2).  Retrograde signaling targets 
transcription factors such as cyclic-AMP response element binding protein (CREB) and 
Myocyte enhancing factor 2 (MEF2) (114, 147), both of which expressed a higher level 
of activity in Zhangfei-expressing cells (2.1 and 1.5 fold increases, respectively) as 
discovered in the transcription factor profiling array (Figure 3.7).   
In some instances, TrkA signaling has been shown to correlate with JNK 
activation resulting in cell death (59).  In turn, JNK signaling may activate transcription 
factor c-Jun (56).  Inhibition of JNK signaling has been shown to ablate apoptotic 
signaling by Bax (73).  Overexpression of c-Jun and activation of JNK signaling have 
both been shown to increase p53 stabilization and accumulation in mouse fibroblasts (39, 
70).  The transcriptional activity of p53 was upregulated in Zhangfei-expressing cells 
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according to the transcription factor profiling array (Figure 3.7).  p53 has also been linked 
to TrkA-induced apoptosis in neuroblastoma cells (69).  p53 has been shown to directly 
increase the transcription of pro-apoptotic protein PUMA (BBC3) (47, 146), which in 
turn directly interacts (not shown) with pro-apoptotic Bax and anti-apoptotic Bcl-2 to 
induce cell death (90).  Bcl-2 transcripts were downregulated in Zhangfei-expressing 
cells.  Bcl-2 plays a role in inhibiting ATG6 (Beclin 1) dependent autophagy (107).  
Removal of the inhibitory effects of Bcl-2 may turn its role from stabilizing cellular 
autophagy to allowing overactivation of autophagy.  Removal of Bcl-2 inhibition of Bax 
allows for the activation of apoptosis (101).  In any case, the activation of autophagy 
and/or apoptosis appears to be a balancing act.  Much crosstalk occurs between these two 
programmed cellular death pathways, as reviewed in (81). 
 My results support a model in which autocrine NGF-TrkA stimulation leads to 
the possible differentiation and eventual death of ONS-76 cells that express Zhangfei.  
The mechanism of cell death points to apoptosis.  Autophagy accompanies cell death in 
what appears to be a part of the natural death process.  TrkA-induced apoptosis and 
autophagy are frequently referenced in the studies of neurological tumors.  Apoptosis 
appeared to be at least partially reliant on MEK, JNK, and TrkA activation.  Further work 
must identify the DNA binding partner(s) of Zhangfei or discover the role of tumor 
necrosis family members in Zhangfei-induced cell death.  In time, Zhangfei may also 
prove to be a great candidate for translational cancer research. 
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Chapter 5: Supplementary Data  
 
 
S1.  Data from Neurogenesis qRT-PCR Array.  All genes involved in the array, including 
P-value and Fold Regulation. 	  
Neurogenesis Position Symbol P-Value Fold Regulations 
 A03  ADORA2A 0.134095 4.88 
 A04  ALK 0.030613 4.28 
 A05  APBB1 0.002246 39.17 
 A10  BAI1 0.063245 5.59 
 B03  BMP8B 0.001451 6.54 
 B10  DLG4 0.000088 8.85 
 C04  EGF 0.000166 8.89 
 G04  S100B 0.015575 5.36 
 A12  BMP15 0.373895 -10.07 
 C08  FGF13 0.133776 -12.37 
 C11  GDNF 0.000441 -8.05 
 D10  INHBA 0.001502 -4.05 
 A01  ACHE 0.27484 3.16 
 A02  ADORA1 0.049346 2.44 
 A06  APOE 0.431816 -1.32 
 A07  ARNT2 0.086183 -1.56 
 A08  ARTN 0.08785 2.03 
 A09  ASCL1 0.568213 1.28 
 A11  BDNF 0.334031 -1.97 
 B01  BMP2 0.8604 1.36 
 B02  BMP4 0.026032 2.3 
 B04  CDK5R1 0.663732 -1.14 
 B05  CDK5RAP1 0.978707 1.01 
 B06  CDK5RAP2 0.002645 1.73 
 B07  CDK5RAP3 0.50241 1.1 
 B08  CHRM2 0.816317 1.23 
 B09  CXCL1 0.888359 -1.13 
 B11  DLL1 0.002265 -2.58 
 B12  DRD1 0.42767 1.96 
 C01  DRD2 0.571029 -1.2 
 C02  DVL3 0.346619 1.42 
 C03  EFNB1 0.19328 -1.9 
 C05  EP300 0.905443 -1.89 
 C06  ERBB2 0.081301 2.36 
 C07  FEZ1 0.002139 -1.46 
 C09  FGF2 0.44026 -1.21 
 C10  FLNA 0.074127 -2.7 
 C12  GNAO1 0.028456 -2.33 
 D01  GPI 0.003156 1.8 
 D02  GRIN1 0.915018 1.03 
 D03  HDAC4 0.038867 2.26 
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 D04  HDAC7 0.023736 1.91 
 D05  HES1 0.567474 1.12 
 D06  HEY1 0.056637 -3.48 
 D07  HEY2 0.763158 1.16 
 D08  HEYL 0.327698 1.42 
 D09  IL3 0.901606 1.02 
 D11  MDK 0.013283 -3.13 
 D12  MEF2C 0.72825 -1.1 
 E01  MLL 0.321081 1.48 
 E02  NCOA6 0.040438 1.77 
 E03  NDN 0.092005 -3.56 
 E04  NDP 0.006592 -2.99 
 E05  NEUROD1 0.901606 1.02 
 E06  NOG 0.100152 -3.02 
 E07  NOTCH2 0.442984 -1.34 
 E08  NPTX1 0.394996 2.05 
 E09  NRCAM 0.502812 1.48 
 E10  NRG1 0.037444 -3.25 
 E11  NRP1 0.473606 1.19 
 E12  NRP2 0.036131 -3.58 
 F01  NTN1 0.290834 1.32 
 F02  ODZ1 0.167855 1.26 
 F03  PAFAH1B1 0.441026 1.13 
 F04  PARD3 0.792798 -1.07 
 F05  PARD6B 0.002127 3.05 
 F06  PAX3 0.901606 1.02 
 F07  PAX5 0.901606 1.02 
 F08  PAX6 0.016455 2.1 
 F09  POU3F3 0.901606 1.02 
 F10  POU4F1 0.34516 -1.21 
 F11  PTN 0.094448 -1.56 
 F12  RAC1 0.029686 1.24 
 G01  ROBO1 0.337905 1.27 
 G02  RTN4 0.367126 1.2 
 G03  S100A6 0.001077 -1.89 
 G05  SEMA4D 0.010939 2.16 
 G06  SHH 0.004646 -1.82 
 G07  SLIT2 0.690641 1.17 
 G08  SOX8 0.901606 1.02 
 G09  STAT3 0.099216 1.25 
 G10  TNR 0.73432 -1.29 
 G11  VEGFA 0.976868 -1.04 
 G12  YWHAH 0.181997 1.32 
 H01  B2M 0.01057 1.81 
 H02  HPRT1 0.07691 1.51 
 H03  RPL13A 0.001555 -2.38 
 H04  GAPDH 0.003638 -1.67 
 H05  ACTB 0.112931 -1.64 
 H06  HGDC 0.567029 1.03 
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 H07  RTC 0.298577 1.26 
 H08  RTC 0.67651 1.07 
 H09  RTC 0.805508 -1.13 
 H10  PPC 0.384121 -1.22 
 H11  PPC 0.282891 -1.18 
 H12  PPC 0.365474 -1.2 	  
 
S2.  Data from Apoptosis qRT-PCR Array.  All genes involved in the array, including P-
value and Fold Regulation. 	  
Apoptosis Position Symbol P-Value Fold Regulations 
 D10  CD40 0.006885 6.87 
 F06  TNF 0.016471 4.44 
 G02  TNFRSF9 0.000933 8.74 
 C11  CASP1 0.000015 -4 
 E01  CIDEA 0.011967 -6.69 
 A01  ABL1 0.011676 1.7 
 A02  AKT1 0.000113 1.86 
 A03  APAF1 0.030334 1.34 
 A04  BAD 0.000602 2.6 
 A05  BAG1 0.622715 -1.03 
 A06  BAG3 0.447659 1.05 
 A07  BAG4 0.031516 1.44 
 A08  BAK1 0.031049 1.37 
 A09  BAX 0.043794 1.26 
 A10  BCL10 0.770888 1.11 
 A11  BCL2 0.021578 -1.36 
 A12  BCL2A1 0.232434 1.49 
 B01  BCL2L1 0.001461 -1.99 
 B02  BCL2L10 0.182863 1.61 
 B03  BCL2L11 0.006876 1.92 
 B04  BCL2L2 0.42448 1.15 
 B05  BCLAF1 0.495807 -1.25 
 B06  BFAR 0.471205 -1.19 
 B07  BID 0.004213 2.25 
 B08  BIK 0.003272 -1.45 
 B09  NAIP 0.071942 1.39 
 B10  BIRC2 0.046717 1.38 
 B11  BIRC3 0.502458 -1.13 
 B12  XIAP 0.170154 1.2 
 C01  BIRC6 0.000632 2.47 
 C02  BIRC8 0.031713 1.25 
 C03  BNIP1 0.393466 1.17 
 C04  BNIP2 0.104713 1.34 
 C05  BNIP3 0.450553 -1.15 
 C06  BNIP3L 0.080085 -1.12 
 C07  BRAF 0.00981 2.11 
 C08  NOD1 0.064752 1.49 
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 C09  CARD6 0.06253 -1.61 
 C10  CARD8 0.270368 -1.21 
 C12  CASP10 0.04806 -1.23 
 D01  CASP14 0.031713 1.25 
 D02  CASP2 0.326284 1.1 
 D03  CASP3 0.013723 1.15 
 D04  CASP4 0.151276 1.08 
 D05  CASP5 0.245093 -1.23 
 D06  CASP6 0.206896 -1.15 
 D07  CASP7 0.064806 1.49 
 D08  CASP8 0.706153 1.03 
 D09  CASP9 0.004937 2.23 
 D11  CD40LG 0.031713 1.25 
 D12  CFLAR 0.001577 -1.3 
 E02  CIDEB 0.055223 1.66 
 E03  CRADD 0.027705 -1.3 
 E04  DAPK1 0.031713 1.25 
 E05  DFFA 0.121682 -1.32 
 E06  FADD 0.044155 1.33 
 E07  FAS 0.014663 -1.51 
 E08  FASLG 0.031713 1.25 
 E09  GADD45A 0.007448 -1.5 
 E10  HRK 0.76486 1 
 E11  IGF1R 0.007518 1.28 
 E12  LTA 0.992385 1.13 
 F01  LTBR 0.041144 -1.45 
 F02  MCL1 0.406905 1.09 
 F03  NOL3 0.172055 -1.17 
 F04  PYCARD 0.126064 1.84 
 F05  RIPK2 0.001025 -1.49 
 F07  TNFRSF10A 0.176009 2.04 
 F08  TNFRSF10B 0.00628 1.43 
 F09  TNFRSF11B 0.005613 1.43 
 F10  TNFRSF1A 0.870007 -1.03 
 F11  TNFRSF21 0.000001 -1.53 
 F12  TNFRSF25 0.928636 1.08 
 G01  CD27 0.551223 -1.13 
 G03  TNFSF10 0.000002 -2.79 
 G04  CD70 0.001792 1.72 
 G05  TNFSF8 0.031713 1.25 
 G06  TP53 0.094841 1.21 
 G07  TP53BP2 0.047614 1.6 
 G08  TP73 0.854236 -1.02 
 G09  TRADD 0.043231 1.22 
 G10  TRAF2 0.692709 1.04 
 G11  TRAF3 0.029393 1.5 
 G12  TRAF4 0.485668 1.08 
 H01  B2M 0.001989 2.01 
 H02  HPRT1 0.004366 1.6 
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 H03  RPL13A 0.000009 -2.53 
 H04  GAPDH 0.788761 -1.01 
 H05  ACTB 0.261468 -1.26 
 H06  HGDC 0.333312 -1.24 
 H07  RTC 0.003204 1.12 
 H08  RTC 0.102124 1.18 
 H09  RTC 0.231264 1.13 
 H10  PPC 0.424103 1.07 
 H11  PPC 0.643606 1.05 
 H12  PPC 0.881998 1 	  	  
S3.  Primer Sequences for qRT-PCR Confirmation of Neurogenesis Array 	  
Gene Name Upstream Primer (51-31) Downstream Primer (51-31) 
APBB1 TCTGTTCCATCATCACTGAGC GTTCTGGCCCTCTTTTAGCC 
EGF TCACCTCAGGGAAGATGACC CAGTTCCCACCACTTCAGG 
DLG4 CACTCCTCACAGTGCTGCATAG CCTGGGGCTTCTAGGGTATC 
BMP8B ATTGGAAGGAGTTCCGCTTTG GTCACTGGCTGCTGTGACATC 
ADORA2A AGGCAGCAAGAACCTTTC CTAAGGAGCTCCACGTCTGG 
ALK GCAACATCAGCCTGAAGAC GCCTGTTGAGAGACCAGGAG 
S100B ATTCTGGAAGGGAGGGAGAC CGTGGCAGGCAGTAGTAACC 
GDNF CCAACCCAGAGAATTCCAG CAACATGCCTGCCCTACTTTG 
BMP15 GATTCCTCAAAACCTTCCCTG CAAGAAGGCAATGTCAAGGATG 
FGF13 GGGTGGTATCTGGGTCTGAAC CATTGTGGCTCATGGATTTG 	  
S4.  Primer Sequences for qRT-PCR Confirmation of Apoptosis Array 	  
Gene Name Upstream Primer (51-31) Downstream Primer (51-31) 
TNFRSF9 GTCGACCCTGGACAAACTG TTTCTGCCCCGTTTAACAAC 
CD40 GCAGGCACAAACAAGACTG TCGGGAAAATTGATCTCCTG 
TNF AGCCCATGTTGTAGCAAACC GATGGCAGAGAGGAGGTTG 
CASP2 CTCAGGCTCAGAAGGGAATG CGCTGTACCCCAGATTTTG 
CIDEA ACTCTGGTGCTGGAGGAAG TTAAGGCAGCCGATGAAGTC 	  	  
S5.  Primer Sequences for Autophagy Response Gene Regulation 	  
Gene 
Name 
Upstream Primer (51-31) Downstream Primer (51-31) 
ATG5 GCAAGCCAGACAGGAAAAAG 
 
GACCTTCAGTTGGTCCGGTAA 
ATG6 
(Beclin 1) 
CAAGATCCTGGACCGTGTCA TGGCACTTTCTGTGGACATCA 
ATG7 CAGGAGATTCAACCAGAGAC AGATACCATCAATTCCACGG 
BCL2 TGCACCTGACGCCCTTCAC AGACAGCCAGGAGAAATCAAACAG 	  
S6.  Other Primers 	  
TrkA GAGGGCAAAGGCTCTGGACTCCA AGACTCCGAAGCGCACGATG 
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Zhangfei CTGACCACCTCCCTCTTCAG CAGAACTCCACCGACACCTT 
GAPDH GCCTCCTGCACCACCAACTG GGGCCATCCACAGTCTTCTGG 
Brn3a GGTACCTAAAGACCAGAGCTTCTTTG CTCGAGGACGGGATGCACTCCTCTAA 	  	  
S7.  Kinome Array Results. Raw Data for Adeno-LacZ-infected ONS-76 cells. P value 
cutoff of 0.05. 
 
Gene Name 
Target  amino 
acid  Genbank 
ZF2/3 vs. 
Lac2/3 up 
ZF3 vs. Lac3 
down 
ZF2/3 vs. 
Lac2/3 fold 
change 
EphA2 Y772 P29317 0.001182825 0.998817175 1.49736966 
TAK1 T184 O43318 0.002025469 0.997974531 1.516308493 
IRF-3 S396/8 Q14653 0.003606114 0.996393886 1.17174897 
STAT1 S727 P42224 0.003942177 0.996057823 1.649226326 
IRF-3 S385/6 Q14653 0.004410719 0.995589281 2.540041177 
Crk Y221 P46108 0.00667695 0.99332305 1.955734327 
NFκB-p65 S311 Q04206 0.007252056 0.992747944 1.517852368 
JNK3 T131 P53779 0.007362009 0.992637991 1.832600522 
PKACa T195/7 P17612 0.007449918 0.992550082 1.338862612 
Notch 2 S2070 Q04721 0.008756818 0.991243182 1.230074244 
P38 gamma Y323 P53778 0.009783959 0.990216041 1.530096159 
HSP70 Y525/6 P08107 0.012666251 0.987333749 1.662024614 
PLCB1 S887 Q9NQ66 0.016572549 0.983427451 1.354325672 
SEK1 S257/0 P45985 0.017410418 0.982589582 2.029644341 
Grb10 S150 Q13322 0.018172481 0.981827519 2.41114841 
IL-8R B S351/2/3 P25025 0.025055239 0.974944761 2.535084431 
RBL2_SYMSP    0.028253779 0.971746221 2.71942569 
JNK2 T404/7 P45984 0.029525338 0.970474662 1.727325571 
Fos T232 P01100 0.029706366 0.970293634 1.504427419 
STAT3 S727 P40763 0.032854427 0.967145573 1.27412846 
smMLCK S1773 Q15746 0.03313294 0.96686706 1.661472308 
STAT2 Y690 P52630 0.034178239 0.965821761 1.376355601 
Jun S63 P05412 0.034736712 0.965263288 1.704580746 
IL-8R B S347 P25025 0.03512201 0.96487799 1.511224568 
mucin 1 T1224/7/9 P15941 0.036684837 0.963315163 1.941291022 
PKCA T637 P17252 0.039731572 0.960268428 1.925225712 
p38-alpha T180/2 Q16539 0.041880534 0.958119466 1.162071137 
LRRFIP1 S497 O75766 0.042424626 0.957575374 3.027104247 
NFAT1 S168 Q13469 0.042504237 0.957495763 1.491589421 
DNA-PK T2609 P78527 0.042762478 0.957237522 1.324442277 
PKCB S15/T16 P05771 0.04567759 0.95432241 2.706194326 
CBP S2063 Q92793 0.046209337 0.953790663 1.529325351 
MKP-1 S359 P28562 0.048462642 0.951537358 1.736547796 
ROCK2 S1134/7 O75116 0.050251176 0.949748824 1.335235318 
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Fyn Y420 P06241 0.054586169 0.945413831 1.496852463 
A-Raf Y301 P10398 0.944672698 0.055327302 -2.145914408 
Syk Y525/6 P43405 0.94768683 0.05231317 -3.025678652 
HIF2A T840 Q99814 0.953227317 0.046772683 -1.71369426 
Rac1 S71 P63000 0.956010615 0.043989385 -2.176177994 
iNOS S909 P35228 0.959586405 0.040413595 -1.581918507 
PLCG1 Y771 P19174 0.962451241 0.037548759 -1.816040381 
Daxx S668/71 Q9UER7 0.965074364 0.034925636 -1.459165917 
IL2RB Y364 P14784 0.965617966 0.034382034 -1.948832808 
ERK1 T202/4 P27361 0.970147937 0.029852063 -1.764253426 
MSK2 S347 O75676 0.971279178 0.028720822 -1.625341223 
gp130 Y767 P40189 0.972195063 0.027804937 -1.580191733 
iNOS S739 P35228 0.975169646 0.024830354 -1.347776557 
Bad S118 Q92934 0.975675385 0.024324615 -1.593990167 
ERK2 Y205 P28482 0.978745366 0.021254634 -2.109913446 
ERK3 S189 Q16659 0.979683061 0.020316939 -1.771565013 
RIPK1 Y384/7/9 Q13546 0.984376253 0.015623747 -1.285943955 
FLT3 Y597/9 P36888 0.986271203 0.013728797 -1.854424216 
IL-10R-A Y496 Q13651 0.987804951 0.012195049 -1.891010914 
PKCT T219 Q04759 0.989940275 0.010059725 -1.401619199 
VEGFR3 Y130/1 P35916 0.990994175 0.009005825 -2.137667104 
IRAK1 T100 P51617 0.991862373 0.008137627 -1.527571122 
4E-BP1 T37 Q13541 0.992806839 0.007193161 -2.600597579 
Src S96 P12931 0.993747456 0.006252544 -2.356887655 
MSK1 T581 O75582 0.997733589 0.002266411 -1.912427531 
SOD1 S98 P00441 0.99799347 0.00200653 -2.440491216 	  	  
S8.  Total Test Proteins in Kinome Array 	  
Total Kinome Array Test Proteins   
4E-BP1  CTNNB1 H-Ras-1  MEK5  PPP2CA  
4E-BP1  CTNNB1 HSP27  MEKK1  PTP1B  
ADCY8 CTNNB1 HSP60 Met  PXN 
Akt1 CTSB HSP70  Met  Pyk2  
Akt1 CXCR4  IFNAR1  MKP-1  RAC1  
Akt1  cyclin D1  IFNAR1  MKP-1  Raf1  
Akt1  cyclin E1  IFNGR1  MKP-1  Raf1  
Akt3  Cystatin S IFNGR1  MLK3  RasGAP  
Akt3  DAPK1  IGF1R  Mos  Rb  
APE1 DAPK1  IkB-alpha  MSK1  Rb  
Aplp1 DAPK3 IkB-alpha  MSK2  RBL2_SYMSP  
ApoE DAPK3 IkB-beta  MSK2  RelB  
A-Raf DAPP1  IkB-beta  mucin 1  RhoA  
ASK1  Daxx  IKK-alpha  NFAT1  RIPK1  
ASK1  DNA-PK  IKK-beta  NFAT1  ROCK2  
ASK1  DNA-PK  IKK-beta  NFAT2  SEK1  
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ATF-2  Elk-1  IKK-gamma  NFAT4  SEK1  
ATF-2  Elk-1  IKK-gamma  NFκβ-p100  Shc1 
ATF-4  eNOS  IL-10R-A  NFκβ-p100  Smad1  
axin-1  EphA1  IL-16  NFκβ-p105  Smad2  
Bad  EphA2  IL1A  NFκβ-p105  Smad2  
BATF  EphA2  IL2RB  NFκβ-p65  Smad3  
BCAP  EphA2  IL2RB  NFκβ-p65  Smad3  
BCAP  ERK1  IL4R  NFκβ-p65  smMLCK  
Bcl-2 ERK2  IL7R  NGFR  SOD1 
Bcl-2 ERK3  IL-8R B  Nik  Src  
Bid  Etk  IL-8R B  Notch 2  Src  
BLNK  Ezrin iNOS  Notch 2  SRF  
BLNK  FADD  iNOS  p300  STAT1  
B-Raf FADD  iNOS  p300  STAT1  
Btk  FAK  IRAK1  P38 gamma STAT2  
Btk  Fas  IRAK1  p38-alpha  STAT3  
Calmodulin  Fas  IRAK1  p38-alpha  STAT3  
CaMK2-alpha  Fes  IRAK1  p40phox  STAT4  
Casp3  FGFR1  IRAK1  p47phox  STAT4  
Casp8  FGFR1  IRF-3  p53  STAT5B  
caveolin-1 FGFR1  IRF-3  p53  STAT5B  
Cbl FGFR3  IRF-3  p70S6Kb  STAT6  
CBP  FGFR3  IRF-5  PDGFRb  STMN1  
CCR2  FGFR4  ITK  PDGFRb  STMN1  
CCR5  FLGE_ECOLI  Jak1  PIK3R1  Syk  
CCR7  FLT3  Jak2  PKACa  TAK1  
CCR7  FLT3  Jak3  PKACa  TAK1  
CD28  Fos  JIP1  PKCA  TBK1  
CD45  FRS2  JNK1 PKCA  TNF-R1  
CD45  FRS2  JNK1  PKCB  TNFRSF5  
Cdc25A  FRS3  JNK2  PKCB  TNIK  
Cdc25A  Fyn JNK2  PKCE  TNIK  
Cdc42  Fyn JNK3  PKCE  TPH1  
CDK2  GCAP2 Jun  PKCT  TrkB  
CDK2  gp130  Jun  PKCT  TrkC  
CDK7  gp130  Kit  PKG1  Tyk2  
Cot  gp130  Kit  PKR  VASP  
CREB  Grb10  LEF-1 PKR  VEGFR-1  
CREB  Grb2 LEF-1 PLCB1  VEGFR-2  
Crk  GSK3-beta  LRRFIP1  PLCB1  VEGFR3  
CSFR  GSK3-beta  LRRFIP1  PLCG1  VEGFR3  
CSFR  HIF1A  Lyn  PLCG1  VIM 
CSK  HIF2A  MEK1  PLCG1  WASP  
CTLA-4  HMGA1  MEK2  PPARG  XIAP  	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S9. Transcription Factor Profiling Array.  Transcription factor symbols on top, relative 
luminocity below. 	  
  Adeno-Zhangfei infection – raw data                     Adeno-LacZ infection – raw data 	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